RGD DISEASE ONTOLOGY - ANNOTATIONS |
|
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
|
Term: | Chemically-Induced Disorders |
|
Accession: | DOID:9008261
|
browse the term
|
Definition: | Disorders caused by the intentional or unintentional ingestion or exposure to chemical substances such as PHARMACEUTICAL PREPARATIONS; NOXAE; and PESTICIDES. |
Synonyms: | exact_synonym: | Chemically-Induced Disorder |
| primary_id: | MESH:D064419; RDO:0015820 |
| subset: | RGD_JBrowse_slim |
For additional species annotation, visit the
Alliance of Genome Resources.
|
|
|
|
G |
Aldh2 |
aldehyde dehydrogenase 2 family member |
|
ISO |
ClinVar Annotator: match by term: Susceptibility to hangover ClinVar Annotator: match by term: Acute alcohol sensitivity CTD Direct Evidence: marker/mechanism |
OMIM ClinVar CTD |
PMID:2987944 PMID:4065146 PMID:6650498 PMID:7180842 PMID:7593603 PMID:8903321 PMID:10627091 PMID:10780266 PMID:15654505 PMID:16046871 PMID:16440063 PMID:17885622 PMID:18056758 PMID:20010786 PMID:25741868 PMID:33355142 |
|
NCBI chr12:40,466,418...40,498,813
Ensembl chr12:40,466,495...40,498,752
|
|
|
G |
Adh1 |
alcohol dehydrogenase 1 (class I) |
|
ISO ISS |
ClinVar Annotator: match by term: Alcohol dependence OMIM:103780 |
ClinVar MouseDO |
PMID:3397059 PMID:3758060 PMID:10090900 PMID:15863807 PMID:17718394 PMID:17923853 |
|
NCBI chr 2:243,550,655...243,562,243
Ensembl chr 2:243,550,627...243,687,857
|
|
G |
Aldh2 |
aldehyde dehydrogenase 2 family member |
|
ISO |
ClinVar Annotator: match by term: Alcohol dependence |
ClinVar |
PMID:2987944 PMID:4065146 PMID:6650498 PMID:7180842 PMID:7593603 PMID:8903321 PMID:10627091 PMID:10780266 PMID:15654505 PMID:16046871 PMID:16440063 PMID:17885622 PMID:18056758 PMID:20010786 PMID:33355142 |
|
NCBI chr12:40,466,418...40,498,813
Ensembl chr12:40,466,495...40,498,752
|
|
G |
Avpr1b |
arginine vasopressin receptor 1B |
|
IEP |
|
RGD |
PMID:21309953 |
RGD:14700679 |
NCBI chr13:48,367,307...48,378,831
Ensembl chr13:48,367,307...48,378,831
|
|
G |
Gabra2 |
gamma-aminobutyric acid type A receptor subunit alpha 2 |
|
ISS |
OMIM:103780 |
MouseDO |
|
|
NCBI chr14:39,662,411...39,801,082
Ensembl chr14:39,661,968...39,798,302
|
|
G |
Ggt1 |
gamma-glutamyltransferase 1 |
|
IEP |
protein:increased activity:plasma,liver,intestine: |
RGD |
PMID:6113606 |
RGD:14701046 |
NCBI chr20:14,019,723...14,045,781
Ensembl chr20:14,019,723...14,025,068
|
|
G |
Gstt1 |
glutathione S-transferase theta 1 |
|
ISO |
|
RGD |
PMID:29582627 |
RGD:14700988 |
NCBI chr20:13,799,102...13,816,527
Ensembl chr20:13,799,102...13,816,526
|
|
G |
Htr2a |
5-hydroxytryptamine receptor 2A |
|
ISS |
OMIM:103780 |
MouseDO |
|
|
NCBI chr15:56,666,152...56,732,469
Ensembl chr15:56,666,012...56,735,382
|
|
G |
Lep |
leptin |
|
IDA IEP |
DNA:hypermethylation:promoter protein:decreased expression:serum |
RGD |
PMID:29912265, PMID:29912265 |
RGD:21201248, RGD:21201248 |
NCBI chr 4:56,337,695...56,351,818
Ensembl chr 4:56,337,695...56,351,818
|
|
G |
Slc29a1 |
solute carrier family 29 member 1 |
|
ISS |
OMIM:103780 |
MouseDO |
|
|
NCBI chr 9:17,784,468...17,799,008
Ensembl chr 9:17,784,468...17,799,005
|
|
|
G |
Atp2a1 |
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 1 |
|
IEP |
|
RGD |
PMID:14506614 |
RGD:1581765 |
NCBI chr 1:197,855,912...197,875,038
|
|
|
G |
Adh1 |
alcohol dehydrogenase 1 (class I) |
|
ISO |
ClinVar Annotator: match by OMIM:103780 CTD Direct Evidence: marker/mechanism |
ClinVar CTD OMIM |
PMID:3397059 PMID:3758060 PMID:10090900 PMID:15863807 PMID:16404797 PMID:17718394 PMID:17923853 |
|
NCBI chr 2:243,550,655...243,562,243
Ensembl chr 2:243,550,627...243,687,857
|
|
G |
Adh5 |
alcohol dehydrogenase 5 (class III), chi polypeptide |
|
IMP |
|
RGD |
PMID:8462548 |
RGD:5129091 |
NCBI chr 2:243,728,500...243,740,907
Ensembl chr 2:243,700,784...243,740,899
|
|
G |
Aldh2 |
aldehyde dehydrogenase 2 family member |
|
ISO |
ClinVar Annotator: match by term: Alcohol dependence CTD Direct Evidence: marker/mechanism |
ClinVar CTD |
PMID:2987944 PMID:4065146 PMID:6650498 PMID:7180842 PMID:7593603 PMID:8903321 PMID:10627091 PMID:10780266 PMID:15654505 PMID:16046871 PMID:16404797 PMID:16440063 PMID:17590986 PMID:17885622 PMID:18056758 PMID:20010786 PMID:33355142, PMID:10780266 |
RGD:734551 |
NCBI chr12:40,466,418...40,498,813
Ensembl chr12:40,466,495...40,498,752
|
|
G |
Bdnf |
brain-derived neurotrophic factor |
|
IEP |
protein:decreased expression:plasma |
RGD |
PMID:32135570 |
RGD:35673317 |
NCBI chr 3:100,768,637...100,819,216
Ensembl chr 3:100,768,637...100,819,210
|
|
G |
Camk2n1 |
calcium/calmodulin-dependent protein kinase II inhibitor 1 |
|
ISO |
mRNA:increased expression:prefrontal cortex |
RGD |
PMID:28714806 |
RGD:18337277 |
NCBI chr 5:156,876,706...156,878,486
Ensembl chr 5:156,876,706...156,878,486
|
|
G |
Cckar |
cholecystokinin A receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:9922984 |
|
NCBI chr14:59,610,939...59,619,786
Ensembl chr14:59,611,434...59,619,783
|
|
G |
Cdk20 |
cyclin-dependent kinase 20 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18438686 |
|
NCBI chr17:1,935,900...1,942,867
Ensembl chr17:1,936,163...1,942,865
|
|
G |
Chrna3 |
cholinergic receptor nicotinic alpha 3 subunit |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18414406 |
|
NCBI chr 8:59,594,007...59,607,122
Ensembl chr 8:59,592,403...59,607,275
|
|
G |
Chrna5 |
cholinergic receptor nicotinic alpha 5 subunit |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18414406 |
|
NCBI chr 8:59,561,817...59,590,172
Ensembl chr 8:59,561,721...59,590,172
|
|
G |
Comt |
catechol-O-methyltransferase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:10395222 |
|
NCBI chr11:86,715,981...86,735,630
Ensembl chr11:86,715,981...86,735,622
|
|
G |
Crh |
corticotropin releasing hormone |
|
IEP |
mRNA:increased expression:central amygdaloid nucleus (rat) |
RGD |
PMID:20060104 |
RGD:5508173 |
NCBI chr 2:104,459,999...104,461,863
Ensembl chr 2:104,459,999...104,461,863
|
|
G |
Crhr1 |
corticotropin releasing hormone receptor 1 |
|
ISO |
|
RGD |
PMID:11988580 |
RGD:734822 |
NCBI chr10:92,191,473...92,233,662
Ensembl chr10:92,191,718...92,232,645
|
|
G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
ISO IEP |
CTD Direct Evidence: marker/mechanism protein:increased expression:plasma, extracellular exosome |
CTD |
PMID:20843640, PMID:23819932, PMID:29404485, PMID:29404485 |
RGD:14700915, RGD:14700911, RGD:14700911 |
NCBI chr 1:213,511,892...213,522,195
Ensembl chr 1:213,511,874...213,535,542
|
|
G |
Dbh |
dopamine beta-hydroxylase |
no_association |
ISO |
DNA:polymorphism:5' utr:g.-1021C>T (human) DNA:polymorphism:cds:g.444G>A (human) |
RGD |
PMID:16133787, PMID:16252068 |
RGD:1625572, RGD:1625571 |
NCBI chr 3:5,709,236...5,731,895
Ensembl chr 3:5,709,236...5,731,898
|
|
G |
Drd2 |
dopamine receptor D2 |
|
IEA |
|
GAD |
PMID:15118671 |
RGD:1331525 |
NCBI chr 8:53,678,777...53,743,643
Ensembl chr 8:53,678,777...53,743,642
|
|
G |
Ercc1 |
ERCC excision repair 1, endonuclease non-catalytic subunit |
|
IEP |
|
RGD |
PMID:23095216 |
RGD:10045658 |
NCBI chr 1:80,256,973...80,268,198
Ensembl chr 1:80,256,973...80,268,198
|
|
G |
Fshb |
follicle stimulating hormone subunit beta |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:8590623 |
|
NCBI chr 3:98,088,321...98,092,131
Ensembl chr 3:98,088,324...98,092,131
|
|
G |
Gabbr1 |
gamma-aminobutyric acid type B receptor subunit 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22253714 |
|
NCBI chr20:1,955,344...1,984,907
Ensembl chr20:1,955,359...1,984,863
|
|
G |
Gabra2 |
gamma-aminobutyric acid type A receptor subunit alpha 2 |
susceptibility |
ISO |
DNA:SNPs:multiple: CTD Direct Evidence: marker/mechanism |
CTD OMIM |
PMID:22253714, PMID:15024690 |
RGD:6480257 |
NCBI chr14:39,662,411...39,801,082
Ensembl chr14:39,661,968...39,798,302
|
|
G |
Gabrg2 |
gamma-aminobutyric acid type A receptor subunit gamma 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22253714 |
|
NCBI chr10:27,090,913...27,179,786
Ensembl chr10:27,092,827...27,179,900
|
|
G |
Gata4 |
GATA binding protein 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20585342 |
|
NCBI chr15:46,386,703...46,458,679
Ensembl chr15:46,386,712...46,432,965
|
|
G |
Ggt1 |
gamma-glutamyltransferase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12747453 |
|
NCBI chr20:14,019,723...14,045,781
Ensembl chr20:14,019,723...14,025,068
|
|
G |
Ghsr |
growth hormone secretagogue receptor |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:23977009 |
|
NCBI chr 2:113,065,953...113,071,265
Ensembl chr 2:113,066,885...113,070,261
|
|
G |
Gphn |
gephyrin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22253714 |
|
NCBI chr 6:101,327,874...101,859,169
Ensembl chr 6:101,532,518...101,859,164
|
|
G |
Grin1 |
glutamate ionotropic receptor NMDA type subunit 1 |
|
ISO |
|
RGD |
PMID:14573320 |
RGD:1642372 |
NCBI chr 3:2,507,745...2,534,664
Ensembl chr 3:2,506,896...2,534,663
|
|
G |
Grin2b |
glutamate ionotropic receptor NMDA type subunit 2B |
|
ISO |
|
RGD |
PMID:14573320, PMID:16911840 |
RGD:1642372, RGD:1642200 |
NCBI chr 4:169,541,620...170,000,216
Ensembl chr 4:169,560,387...169,999,873
|
|
G |
Hdac2 |
histone deacetylase 2 |
|
IMP |
|
RGD |
PMID:23485013 |
RGD:9590265 |
NCBI chr20:43,084,870...43,108,198
Ensembl chr20:43,084,870...43,108,198
|
|
G |
Htr2a |
5-hydroxytryptamine receptor 2A |
|
ISO |
|
OMIM |
|
|
NCBI chr15:56,666,152...56,732,469
Ensembl chr15:56,666,012...56,735,382
|
|
G |
Htr3b |
5-hydroxytryptamine receptor 3B |
susceptibility |
ISO |
DNA:SNP:cds:rs1176744(human) |
RGD |
PMID:20838391 |
RGD:6480660 |
NCBI chr 8:53,247,881...53,278,170
Ensembl chr 8:53,248,705...53,277,859
|
|
G |
Htr7 |
5-hydroxytryptamine receptor 7 |
|
ISO |
DNA:SNP:intron:rs7916403(human) |
RGD |
PMID:21046636 |
RGD:6482181 |
NCBI chr 1:254,547,964...254,671,811
Ensembl chr 1:254,547,620...254,671,778
|
|
G |
Kcnj6 |
potassium inwardly-rectifying channel, subfamily J, member 6 |
|
ISO |
DNA:SNP:promoter:rs2836016 (human) |
RGD |
PMID:21307845 |
RGD:6483053 |
NCBI chr11:35,011,007...35,262,362
Ensembl chr11:35,024,196...35,099,383
|
|
G |
Lhb |
luteinizing hormone subunit beta |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:8590623 |
|
NCBI chr 1:101,409,992...101,413,725
Ensembl chr 1:101,410,019...101,413,724
|
|
G |
Maoa |
monoamine oxidase A |
susceptibility |
ISO |
|
RGD |
PMID:15900229 |
RGD:1600720 |
NCBI chr X:6,554,698...6,620,722
Ensembl chr X:6,554,698...6,620,722
|
|
G |
Mcm5 |
minichromosome maintenance complex component 5 |
|
IEP |
|
RGD |
PMID:23095216 |
RGD:10045658 |
NCBI chr19:14,523,482...14,561,281
Ensembl chr19:14,523,554...14,561,278
|
|
G |
Mir191 |
microRNA 191 |
onset |
IEP |
|
RGD |
PMID:32135570 |
RGD:35673317 |
NCBI chr 8:117,354,364...117,354,454
|
|
G |
Mir195 |
microRNA 195 |
onset |
IEP |
|
RGD |
PMID:32135570 |
RGD:35673317 |
NCBI chr10:56,845,301...56,845,387
Ensembl chr10:56,845,301...56,845,387
|
|
G |
Mir206 |
microRNA 206 |
onset |
IEP |
|
RGD |
PMID:32135570 |
RGD:35673317 |
NCBI chr 9:26,791,764...26,791,847
Ensembl chr 9:26,791,764...26,791,847
|
|
G |
Mir30a |
microRNA 30a |
onset |
IEP |
|
RGD |
PMID:32135570 |
RGD:35673317 |
NCBI chr 9:29,542,635...29,542,705
Ensembl chr 9:29,542,635...29,542,705
|
|
G |
Mmp2 |
matrix metallopeptidase 2 |
|
IEP |
|
RGD |
PMID:24966898 |
RGD:13207311 |
NCBI chr19:15,542,771...15,570,589
Ensembl chr19:15,542,765...15,570,611
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
|
IEP |
|
RGD |
PMID:24966898 |
RGD:13207311 |
NCBI chr 3:161,413,410...161,421,473
Ensembl chr 3:161,413,298...161,421,520
|
|
G |
Npy |
neuropeptide Y |
|
IAGP ISO |
DNA:deletion:intron:g.4666_4674del (rat) CTD Direct Evidence: marker/mechanism DNA:missense mutation: :p.L7P (human) |
CTD |
PMID:17572454, PMID:15749341, PMID:12215082 |
RGD:1357412, RGD:10430830 |
NCBI chr 4:79,557,856...79,565,059
Ensembl chr 4:79,557,854...79,565,097
|
|
G |
Npy2r |
neuropeptide Y receptor Y2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18828811 |
|
NCBI chr 2:181,528,949...181,538,145
Ensembl chr 2:181,530,832...181,531,978
|
|
G |
Oprl1 |
opioid related nociceptin receptor 1 |
|
IMP |
|
RGD |
PMID:11814626 |
RGD:9835016 |
NCBI chr 3:177,223,779...177,231,663
Ensembl chr 3:177,225,737...177,231,663
|
|
G |
Oprm1 |
opioid receptor, mu 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12815747 |
|
NCBI chr 1:43,454,803...43,704,948
Ensembl chr 1:43,454,803...43,704,948
|
|
G |
Pde4b |
phosphodiesterase 4B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18438686 |
|
NCBI chr 5:121,759,236...122,136,814
Ensembl chr 5:121,952,977...122,136,814
|
|
G |
Pdyn |
prodynorphin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17559549 PMID:18923396 |
|
NCBI chr 3:122,194,327...122,206,671
Ensembl chr 3:122,194,329...122,206,671
|
|
G |
Penk |
proenkephalin |
|
IEP |
mRNA:increased expression:frontal lobe: |
RGD |
PMID:22703995 |
RGD:10003152 |
NCBI chr 5:17,056,412...17,061,762
Ensembl chr 5:17,056,419...17,061,837
|
|
G |
Rpl18a |
ribosomal protein L18A |
|
IEP |
mRNA:decreased expression:parietal cortex |
RGD |
PMID:11244494 |
RGD:11038708 |
NCBI chr16:20,293,277...20,295,283
Ensembl chr16:20,293,229...20,295,294
|
|
G |
Shbg |
sex hormone binding globulin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:8590623 |
|
NCBI chr10:56,219,861...56,237,354
Ensembl chr10:56,219,858...56,223,245
|
|
G |
Slc6a3 |
solute carrier family 6 member 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27219321 |
|
NCBI chr 1:32,323,011...32,363,983
Ensembl chr 1:32,321,580...32,363,983
|
|
G |
Slc6a4 |
solute carrier family 6 member 4 |
susceptibility |
ISO |
protein:decreased activity: : CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15520362 PMID:17000009, PMID:20838391 |
RGD:6480660 |
NCBI chr10:63,153,656...63,188,377
Ensembl chr10:63,153,651...63,176,463
|
|
G |
Snca |
synuclein alpha |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18055133 |
|
NCBI chr 4:90,782,412...90,883,236
Ensembl chr 4:90,782,374...90,882,285
|
|
G |
Spi1 |
Spi-1 proto-oncogene |
treatment |
IEP IDA |
protein:decreased expression:alveolar macrophage |
RGD |
PMID:16272341, PMID:21447000 |
RGD:9586723, RGD:9586725 |
NCBI chr 3:79,918,127...79,937,708
Ensembl chr 3:79,918,969...79,938,301
|
|
G |
St6gal1 |
ST6 beta-galactoside alpha-2,6-sialyltransferase 1 |
severity |
ISO |
mRNA,protein:decreased expression:liver: |
RGD |
PMID:17697868 |
RGD:10043133 |
NCBI chr11:80,927,601...80,981,424
Ensembl chr11:80,927,601...80,981,422
|
|
G |
Tacr1 |
tachykinin receptor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19204064 |
|
NCBI chr 4:113,247,236...113,416,139
Ensembl chr 4:113,247,795...113,414,504
|
|
G |
Tacr3 |
tachykinin receptor 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18422838 |
|
NCBI chr 2:240,021,152...240,118,971
Ensembl chr 2:240,021,152...240,118,971
|
|
G |
Tas2r118 |
taste receptor, type 2, member 118 |
|
ISO |
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Beta-glycopyranoside tasting |
CTD ClinVar |
PMID:9603606 PMID:10923994 PMID:16051168 PMID:16385453 PMID:17250611 PMID:24177185 |
|
NCBI chr 4:51,002,218...51,003,117
Ensembl chr 4:51,002,218...51,003,117
|
|
G |
Tas2r138 |
taste receptor, type 2, member 138 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17250611 |
|
NCBI chr 4:68,831,221...68,832,216
Ensembl chr 4:68,831,221...68,832,216
|
|
G |
Tbx19 |
T-box transcription factor 19 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18438686 |
|
NCBI chr13:83,403,263...83,426,305
Ensembl chr13:83,403,264...83,425,641
|
|
G |
test |
test1 |
|
TAS |
fr shr 634364 |
RGD |
PMID:16923148 |
RGD:1598390 |
|
|
G |
Tf |
transferrin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:11000917 PMID:21792595 |
|
NCBI chr 8:111,694,570...111,721,275
Ensembl chr 8:111,673,547...111,721,333
|
|
G |
Tph1 |
tryptophan hydroxylase 1 |
|
ISO |
|
RGD |
PMID:15654285 |
RGD:1580464 |
NCBI chr 1:102,669,868...102,699,442
Ensembl chr 1:102,669,868...102,699,442
|
|
|
G |
Cnr1 |
cannabinoid receptor 1 |
|
ISO |
|
RGD |
PMID:11841893 |
RGD:1626329 |
NCBI chr 5:49,307,584...49,333,064
Ensembl chr 5:49,311,030...49,333,056
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
ISO |
|
RGD |
PMID:16318954 |
RGD:5688289 |
NCBI chr13:67,351,230...67,356,920
Ensembl chr13:67,351,087...67,359,335
|
|
G |
Slc6a3 |
solute carrier family 6 member 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27219321 |
|
NCBI chr 1:32,323,011...32,363,983
Ensembl chr 1:32,321,580...32,363,983
|
|
|
G |
Slc29a1 |
solute carrier family 29 member 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21283641 |
|
NCBI chr 9:17,784,468...17,799,008
Ensembl chr 9:17,784,468...17,799,005
|
|
G |
Slc6a3 |
solute carrier family 6 member 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27219321 |
|
NCBI chr 1:32,323,011...32,363,983
Ensembl chr 1:32,321,580...32,363,983
|
|
|
G |
Aif1 |
allograft inflammatory factor 1 |
|
IEP |
protein:increased expression:cortex, hippocampus (rat) |
RGD |
PMID:18585922 |
RGD:2313030 |
NCBI chr20:5,161,350...5,167,176
Ensembl chr20:5,161,333...5,166,448
|
|
G |
Cirbp |
cold inducible RNA binding protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24223948 |
|
NCBI chr 7:12,400,066...12,405,054
Ensembl chr 7:12,401,207...12,405,022
|
|
|
G |
Aldh2 |
aldehyde dehydrogenase 2 family member |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26711020 |
|
NCBI chr12:40,466,418...40,498,813
Ensembl chr12:40,466,495...40,498,752
|
|
G |
Foxo4 |
forkhead box O4 |
|
IEP |
protein:increased phosphorylation:small intestine: |
RGD |
PMID:23292333 |
RGD:10402360 |
NCBI chr X:71,155,284...71,162,158
Ensembl chr X:71,155,601...71,162,158
|
|
G |
Gsr |
glutathione-disulfide reductase |
treatment |
IEP |
|
RGD |
PMID:24972622 |
RGD:10401897 |
NCBI chr16:62,197,617...62,239,987
Ensembl chr16:62,197,617...62,241,361
|
|
|
G |
Ppa2 |
inorganic pyrophosphatase 2 |
|
ISO |
ClinVar Annotator: match by term: Sudden cardiac failure, alcohol-induced |
ClinVar OMIM |
PMID:25741868 PMID:27523597 PMID:27523598 PMID:28492532 PMID:30384889 |
|
NCBI chr 2:238,528,978...238,606,903
Ensembl chr 2:238,529,074...238,606,905
|
|
|
G |
Cartpt |
CART prepropeptide |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22823101 |
|
NCBI chr 2:30,125,249...30,127,408
Ensembl chr 2:30,125,249...30,127,269
|
|
G |
Casp8 |
caspase 8 |
treatment |
IEP |
|
RGD |
PMID:30118883 |
RGD:13782287 |
NCBI chr 9:65,614,142...65,662,624
Ensembl chr 9:65,614,142...65,662,106
|
|
|
G |
Ace |
angiotensin I converting enzyme |
|
ISO |
|
GAD |
PMID:15118671 |
RGD:1331525 |
NCBI chr10:94,170,766...94,213,831
Ensembl chr10:94,170,766...94,187,822
|
|
G |
Agt |
angiotensinogen |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22497828 |
|
NCBI chr19:57,321,594...57,333,460
Ensembl chr19:57,321,640...57,333,433
|
|
G |
Nos1 |
nitric oxide synthase 1 |
|
IEP |
protein:decreased expression:skeletal muscle, membrane |
RGD |
PMID:17607508 |
RGD:1642138 |
NCBI chr12:44,214,949...44,405,530
Ensembl chr12:44,213,943...44,520,341
|
|
G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
IEP |
protein:increased expression:heart myocardium |
RGD |
PMID:18783396 |
RGD:2301868 |
NCBI chr 4:147,274,055...147,399,383
Ensembl chr 4:147,274,107...147,399,380
|
|
G |
Rxra |
retinoid X receptor alpha |
|
IEP |
|
RGD |
PMID:19791468 |
RGD:2317465 |
NCBI chr 3:6,272,560...6,295,354
Ensembl chr 3:6,211,789...6,295,908
|
|
G |
Slc25a4 |
solute carrier family 25 member 4 |
|
IEP |
mRNA, protein:decreased expression:myocardium |
RGD |
PMID:21169901 |
RGD:9681464 |
NCBI chr16:49,266,903...49,270,698
Ensembl chr16:49,266,903...49,270,698
|
|
|
G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
|
ISO |
protein:increased expression:plasma |
RGD |
PMID:16115302 |
RGD:5686674 |
NCBI chr11:81,330,845...81,344,488
Ensembl chr11:81,330,293...81,344,488
|
|
G |
Adipor2 |
adiponectin receptor 2 |
treatment |
IEP ISO |
|
RGD |
PMID:26115886, PMID:18755807, PMID:27220557, PMID:22013387 |
RGD:25330099, RGD:25824943, RGD:25824939, RGD:25440493 |
NCBI chr 4:151,412,135...151,480,108
Ensembl chr 4:151,414,684...151,428,894
|
|
G |
Aldh2 |
aldehyde dehydrogenase 2 family member |
severity treatment susceptibility |
IDA ISO |
human transgene in mouse model protein:altered processing:liver (mouse) DNA:missense mutation:cds:p.E504K (human) |
RGD |
PMID:17058263, PMID:25457208, PMID:29156373, PMID:29063269 |
RGD:1599041, RGD:15036811, RGD:15036805, RGD:14696776 |
NCBI chr12:40,466,418...40,498,813
Ensembl chr12:40,466,495...40,498,752
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
treatment |
ISO |
|
RGD |
PMID:25557254 |
RGD:14995489 |
NCBI chr10:69,412,065...69,413,863
Ensembl chr10:69,412,017...69,413,870
|
|
G |
Ccr2 |
C-C motif chemokine receptor 2 |
treatment |
ISO |
|
RGD |
PMID:25557254 |
RGD:14995489 |
|
|
G |
Ccr5 |
C-C motif chemokine receptor 5 |
disease_progression |
ISO |
|
RGD |
PMID:27859576 |
RGD:14401742 |
NCBI chr 8:133,192,398...133,215,599
Ensembl chr 8:133,197,032...133,215,614
|
|
G |
Cd36 |
CD36 molecule |
|
ISO |
|
RGD |
PMID:24280415 |
RGD:11041117 |
NCBI chr 4:14,150,309...14,191,498
Ensembl chr 4:14,001,761...14,249,749
|
|
G |
Crp |
C-reactive protein |
|
IEP |
protein:increased expression:serum: |
RGD |
PMID:21806828 |
RGD:9491781 |
NCBI chr13:91,080,448...91,081,358
Ensembl chr13:91,054,974...91,093,713
|
|
G |
Ctsb |
cathepsin B |
|
IEP |
protein:increased activity:liver, cytosol (rat) |
RGD |
PMID:17850215 |
RGD:2315516 |
NCBI chr15:46,316,741...46,337,613
Ensembl chr15:46,316,741...46,337,612
|
|
G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26428356, PMID:25583360, PMID:24064383 |
RGD:14700884, RGD:14700870 |
NCBI chr 1:213,511,892...213,522,195
Ensembl chr 1:213,511,874...213,535,542
|
|
G |
Dnmt1 |
DNA methyltransferase 1 |
|
ISO |
|
RGD |
PMID:22905112 |
RGD:9588654 |
NCBI chr 8:21,922,515...21,968,495
Ensembl chr 8:21,922,515...21,968,495
|
|
G |
Hamp |
hepcidin antimicrobial peptide |
|
IEP |
mRNA:decreased expression:liver |
RGD |
PMID:19253830 |
RGD:11041633 |
NCBI chr 1:89,368,021...89,369,960
Ensembl chr 1:89,368,021...89,369,960
|
|
G |
Ldlr |
low density lipoprotein receptor |
|
IEP |
protein:decreased expression: liver (rat) |
RGD |
PMID:20028367 |
RGD:21410185 |
NCBI chr 8:22,750,425...22,773,305
Ensembl chr 8:22,750,336...22,774,903
|
|
G |
Mir155 |
microRNA 155 |
|
ISO |
|
RGD |
PMID:26867493 |
RGD:25671474 |
NCBI chr11:24,176,603...24,176,667
Ensembl chr11:24,176,603...24,176,667
|
|
G |
Pemt |
phosphatidylethanolamine N-methyltransferase |
|
IEP |
|
RGD |
PMID:17156888 |
RGD:1642369 |
NCBI chr10:46,339,821...46,404,640
Ensembl chr10:46,339,821...46,404,642
|
|
G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18703563 |
|
NCBI chr 7:126,618,872...126,687,282
Ensembl chr 7:126,619,196...126,681,752
|
|
G |
Serpine1 |
serpin family E member 1 |
|
IEP |
mRNA:increased expression:liver (rat) |
RGD |
PMID:25561792 |
RGD:11075083 |
NCBI chr12:22,641,104...22,651,482
Ensembl chr12:22,641,104...22,651,482
|
|
G |
Serpinf1 |
serpin family F member 1 |
|
IEP |
protein:decreased expression:liver |
RGD |
PMID:18996124 |
RGD:2312349 |
NCBI chr10:62,241,750...62,254,145
Ensembl chr10:62,241,756...62,254,287
|
|
G |
Sod1 |
superoxide dismutase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19951287 |
|
NCBI chr11:30,363,282...30,368,858
Ensembl chr11:30,363,280...30,368,862
|
|
G |
Sod2 |
superoxide dismutase 2 |
|
IEP |
|
RGD |
PMID:11477087 |
RGD:1625694 |
NCBI chr 1:47,914,757...47,921,587
Ensembl chr 1:47,914,759...47,921,587
|
|
G |
Stat4 |
signal transducer and activator of transcription 4 |
|
IEP |
|
RGD |
PMID:18296740 |
RGD:7207884 |
NCBI chr 9:54,340,649...54,457,753
Ensembl chr 9:54,287,541...54,484,533
|
|
G |
Tlr4 |
toll-like receptor 4 |
severity |
ISO |
|
RGD |
PMID:29884546, PMID:21463341 |
RGD:14697697, RGD:14700554 |
NCBI chr 5:82,587,424...82,601,056
Ensembl chr 5:82,587,420...82,601,052
|
|
G |
Tnf |
tumor necrosis factor |
susceptibility treatment |
ISO IEP |
DNA:SNP:promoter:-238G>A (human) |
RGD |
PMID:9214463, PMID:20143470 |
RGD:14995434, RGD:38508901 |
NCBI chr20:5,189,382...5,192,000
Ensembl chr20:5,189,390...5,192,000
|
|
|
G |
Abcb11 |
ATP binding cassette subfamily B member 11 |
treatment |
IEP |
|
RGD |
PMID:27939985 |
RGD:15036816 |
NCBI chr 3:55,480,024...55,587,946
Ensembl chr 3:55,480,024...55,587,946
|
|
G |
Agt |
angiotensinogen |
|
ISO |
mRNA:decreased expression:liver |
RGD |
PMID:17258719 |
RGD:1601135 |
NCBI chr19:57,321,594...57,333,460
Ensembl chr19:57,321,640...57,333,433
|
|
G |
Alb |
albumin |
severity |
ISO |
protein:increased expression, modification:urine |
RGD |
PMID:29369844 |
RGD:14694842 |
NCBI chr14:19,176,275...19,191,793
Ensembl chr14:19,176,277...19,191,863
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
severity |
ISO |
RNA:increased expression:liver: |
RGD |
PMID:24429361, PMID:21826694, PMID:10446112 |
RGD:14975280, RGD:14995491, RGD:14995467 |
NCBI chr10:69,412,065...69,413,863
Ensembl chr10:69,412,017...69,413,870
|
|
G |
Ccl3 |
C-C motif chemokine ligand 3 |
severity |
ISO |
|
RGD |
PMID:10446112 |
RGD:14995467 |
NCBI chr10:70,869,516...70,871,066
Ensembl chr10:70,869,513...70,871,066
|
|
G |
Ccl5 |
C-C motif chemokine ligand 5 |
treatment |
ISO IEP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12586603, PMID:31258651 |
RGD:14995304 |
NCBI chr10:70,739,764...70,744,303
Ensembl chr10:70,739,800...70,744,315
|
|
G |
Col1a1 |
collagen type I alpha 1 chain |
|
ISO |
|
RGD |
PMID:1670041 |
RGD:5688335 |
NCBI chr10:82,745,801...82,762,790
Ensembl chr10:82,745,801...82,762,789
|
|
G |
Cpt1a |
carnitine palmitoyltransferase 1A |
treatment |
IEP |
|
RGD |
PMID:27939985 |
RGD:15036816 |
NCBI chr 1:218,568,157...218,629,679
Ensembl chr 1:218,569,510...218,629,678
|
|
G |
Cyp7a1 |
cytochrome P450 family 7 subfamily A member 1 |
treatment |
IEP |
|
RGD |
PMID:27939985 |
RGD:15036816 |
NCBI chr 5:19,358,734...19,368,431
Ensembl chr 5:19,358,734...19,368,431
|
|
G |
Fas |
Fas cell surface death receptor |
treatment |
IEP |
|
RGD |
PMID:27939985 |
RGD:15036816 |
NCBI chr 1:252,589,785...252,624,790
Ensembl chr 1:252,589,785...252,624,790
|
|
G |
Fgf19 |
fibroblast growth factor 19 |
treatment |
IEP |
|
RGD |
PMID:27939985 |
RGD:15036816 |
NCBI chr 1:218,058,405...218,061,693
Ensembl chr 1:218,058,405...218,061,693
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
severity |
ISO |
protein:increased expression:hepatocyte |
RGD |
PMID:1347281 |
RGD:14402038 |
NCBI chr 8:22,035,287...22,047,049
Ensembl chr 8:22,035,256...22,047,059
|
|
G |
Il13 |
interleukin 13 |
|
IEP |
mRNA:increased expression:liver |
RGD |
PMID:16698589 |
RGD:1581860 |
NCBI chr10:38,982,909...38,985,466
Ensembl chr10:38,982,909...38,985,466
|
|
G |
Il18 |
interleukin 18 |
severity |
ISO |
associated alcoholic liver cirrhosis; protein:increased expression:plasma: |
RGD |
PMID:15566508 |
RGD:14696666 |
NCBI chr 8:55,009,666...55,016,286
Ensembl chr 8:54,993,859...55,016,299
|
|
G |
Nfkb1 |
nuclear factor kappa B subunit 1 |
treatment |
IEP |
|
RGD |
PMID:27939985 |
RGD:15036816 |
NCBI chr 2:240,773,520...240,890,053
Ensembl chr 2:240,773,456...240,866,689
|
|
G |
Nfkbia |
NFKB inhibitor alpha |
treatment |
IEP |
|
RGD |
PMID:27939985 |
RGD:15036816 |
NCBI chr 6:76,267,227...76,270,457
Ensembl chr 6:76,267,228...76,270,457
|
|
G |
Nlrp3 |
NLR family, pyrin domain containing 3 |
treatment |
IEP |
|
RGD |
PMID:27939985 |
RGD:15036816 |
NCBI chr10:45,884,324...45,918,290
Ensembl chr10:45,893,018...45,918,254
|
|
G |
Nr0b2 |
nuclear receptor subfamily 0, group B, member 2 |
treatment |
IEP |
|
RGD |
PMID:27939985 |
RGD:15036816 |
NCBI chr 5:151,776,004...151,779,319
Ensembl chr 5:151,776,004...151,779,319
|
|
G |
Nr1h4 |
nuclear receptor subfamily 1, group H, member 4 |
treatment |
IEP |
|
RGD |
PMID:27939985 |
RGD:15036816 |
NCBI chr 7:30,003,429...30,162,095
Ensembl chr 7:30,003,429...30,162,056
|
|
G |
Ppara |
peroxisome proliferator activated receptor alpha |
treatment |
IEP |
|
RGD |
PMID:27939985 |
RGD:15036816 |
NCBI chr 7:126,618,872...126,687,282
Ensembl chr 7:126,619,196...126,681,752
|
|
G |
Slc10a1 |
solute carrier family 10 member 1 |
treatment |
IEP |
|
RGD |
PMID:27939985 |
RGD:15036816 |
NCBI chr 6:104,617,730...104,631,355
Ensembl chr 6:104,617,730...104,631,355
|
|
G |
Srebf1 |
sterol regulatory element binding transcription factor 1 |
treatment |
IEP |
|
RGD |
PMID:27939985 |
RGD:15036816 |
NCBI chr10:46,570,996...46,593,021
Ensembl chr10:46,570,996...46,593,009
|
|
G |
Sts |
steroid sulfatase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26220752 |
|
NCBI chr X:45,420,418...45,428,748
Ensembl chr X:45,420,596...45,428,750
|
|
G |
Sult1e1 |
sulfotransferase family 1E member 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26220752 |
|
NCBI chr14:22,070,861...22,089,264
Ensembl chr14:22,072,024...22,089,248
|
|
G |
Tnf |
tumor necrosis factor |
treatment |
ISO IEP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12586603, PMID:27939985 |
RGD:15036816 |
NCBI chr20:5,189,382...5,192,000
Ensembl chr20:5,189,390...5,192,000
|
|
|
G |
Drd2 |
dopamine receptor D2 |
treatment |
IDA |
|
RGD |
PMID:28300818 |
RGD:13506954 |
NCBI chr 8:53,678,777...53,743,643
Ensembl chr 8:53,678,777...53,743,642
|
|
G |
Ifng |
interferon gamma |
treatment |
ISO |
|
RGD |
PMID:9514301 |
RGD:10755766 |
NCBI chr 7:61,337,383...61,341,419
Ensembl chr 7:61,337,381...61,341,419
|
|
G |
Nps |
neuropeptide S |
|
IDA |
|
RGD |
PMID:19860802 |
RGD:9831199 |
NCBI chr 1:207,508,414...207,512,195
Ensembl chr 1:207,508,414...207,512,195
|
|
G |
Npsr1 |
neuropeptide S receptor 1 |
|
IEP |
mRNA:increased expression:brain |
RGD |
PMID:19860802 |
RGD:9831199 |
NCBI chr 8:25,246,174...25,483,582
Ensembl chr 8:25,246,292...25,482,647
|
|
G |
Per2 |
period circadian regulator 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15608650 |
|
NCBI chr 9:98,555,154...98,597,362
Ensembl chr 9:98,555,169...98,597,359
|
|
|
G |
Aldh2 |
aldehyde dehydrogenase 2 family member |
susceptibility |
ISO |
DNA:missense mutation:cds:p.E504K (human) DNA:missense mutation:cds: (rs671) (human) associated with alcohol dependence;DNA:missense mutation:exon 12:p.E487K (human) |
RGD |
PMID:29779728, PMID:23550892, PMID:11051375 |
RGD:14696777, RGD:15042864, RGD:15042858 |
NCBI chr12:40,466,418...40,498,813
Ensembl chr12:40,466,495...40,498,752
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23274713 |
|
NCBI chr13:26,605,426...26,769,374
Ensembl chr13:26,605,426...26,769,374
|
|
G |
Cat |
catalase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23274713 |
|
NCBI chr 3:93,379,872...93,412,058
Ensembl chr 3:93,379,874...93,412,058
|
|
G |
Cnp |
2',3'-cyclic nucleotide 3' phosphodiesterase |
|
ISO |
protein:decreased expression:brain |
RGD |
PMID:16205370 |
RGD:6483345 |
NCBI chr10:88,490,798...88,497,357
Ensembl chr10:88,490,798...88,497,356
|
|
G |
Col3a1 |
collagen type III alpha 1 chain |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23274713 |
|
NCBI chr 9:52,023,295...52,059,221
Ensembl chr 9:52,023,295...52,059,217
|
|
G |
Crp |
C-reactive protein |
severity |
ISO |
|
RGD |
PMID:22441510 |
RGD:6482305 |
NCBI chr13:91,080,448...91,081,358
Ensembl chr13:91,054,974...91,093,713
|
|
G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20843640, PMID:29404441 |
RGD:14700873 |
NCBI chr 1:213,511,892...213,522,195
Ensembl chr 1:213,511,874...213,535,542
|
|
G |
Fabp2 |
fatty acid binding protein 2 |
onset |
ISO |
DNA:polymorphism:CDS:amino acid A54T, homozygosity of the T allele associated with later onset |
RGD |
PMID:16289894, PMID:16289894 |
RGD:1578455, RGD:1578455 |
NCBI chr 2:227,080,912...227,083,654
Ensembl chr 2:227,080,924...227,083,501
|
|
G |
Il18bp |
interleukin 18 binding protein |
|
ISO |
protein:increased expression:plasma: |
RGD |
PMID:15566508 |
RGD:14696666 |
NCBI chr 1:167,091,521...167,095,727
Ensembl chr 1:167,091,522...167,093,560
|
|
G |
Il6 |
interleukin 6 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23274713 |
|
NCBI chr 4:3,043,231...3,047,807
Ensembl chr 4:3,043,231...3,047,807
|
|
G |
Jak2 |
Janus kinase 2 |
|
ISO |
mRNA, protein:increased expression, increased tyrosine phosphorylation:liver |
RGD |
PMID:24619965 |
RGD:10403061 |
NCBI chr 1:247,398,667...247,457,521
Ensembl chr 1:247,398,598...247,458,509
|
|
G |
Lep |
leptin |
|
IDA |
DNA:hypomethylation:promoter (human) |
RGD |
PMID:29912265 |
RGD:21201248 |
NCBI chr 4:56,337,695...56,351,818
Ensembl chr 4:56,337,695...56,351,818
|
|
G |
Mboat7 |
membrane bound O-acyltransferase domain containing 7 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26482880 |
|
NCBI chr 1:64,100,159...64,114,437
Ensembl chr 1:64,101,018...64,113,792
|
|
G |
Mir122 |
microRNA 122 |
|
ISO |
miRNA:decreased expression:liver |
RGD |
PMID:28987423 |
RGD:14401600 |
NCBI chr18:60,755,285...60,755,369
|
|
G |
Mir141 |
microRNA 141 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28545106 |
|
NCBI chr 4:157,236,346...157,236,439
Ensembl chr 4:157,236,346...157,236,439
|
|
G |
Mir17 |
microRNA 17 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28545106 |
|
NCBI chr15:100,179,879...100,179,962
Ensembl chr15:100,179,879...100,179,962
|
|
G |
Mir193b |
microRNA 193b |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28545106 |
|
NCBI chr14:30,331,049...30,331,131
Ensembl chr14:30,331,049...30,331,131
|
|
G |
Mir423 |
microRNA 423 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28545106 |
|
NCBI chr10:63,098,366...63,098,444
Ensembl chr10:63,098,360...63,098,453
|
|
G |
Mir484 |
microRNA 484 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28545106 |
|
NCBI chr10:27,845...27,921
Ensembl chr10:27,845...27,921
|
|
G |
Mir532 |
microRNA 532 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28545106 |
|
NCBI chr X:16,109,870...16,109,948
Ensembl chr X:16,109,870...16,109,948
|
|
G |
Mir93 |
microRNA 93 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28545106 |
|
NCBI chr12:19,307,543...19,307,629
Ensembl chr12:19,307,543...19,307,629
|
|
G |
Mmp13 |
matrix metallopeptidase 13 |
|
IEP |
|
RGD |
PMID:16286264 |
RGD:10043176 |
NCBI chr 8:5,522,739...5,533,018
Ensembl chr 8:5,522,739...5,533,018
|
|
G |
Mmp2 |
matrix metallopeptidase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23274713 |
|
NCBI chr19:15,542,771...15,570,589
Ensembl chr19:15,542,765...15,570,611
|
|
G |
Mpo |
myeloperoxidase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19731237 PMID:23274713 |
|
NCBI chr10:75,087,892...75,098,260
Ensembl chr10:75,087,892...75,098,260
|
|
G |
Mthfr |
methylenetetrahydrofolate reductase |
susceptibility |
ISO |
DNA:SNP: :677C>T(human) |
RGD |
PMID:25987440 |
RGD:14696749 |
NCBI chr 5:164,844,642...164,864,360
Ensembl chr 5:164,845,925...164,860,910
|
|
G |
Nr1d1 |
nuclear receptor subfamily 1, group D, member 1 |
|
ISO |
|
RGD |
PMID:24497272 |
RGD:10448995 |
NCBI chr10:86,683,875...86,690,815
Ensembl chr10:86,683,875...86,690,815
|
|
G |
Plau |
plasminogen activator, urokinase |
|
IDA |
|
RGD |
PMID:19615318 |
RGD:7241800 |
NCBI chr15:3,644,296...3,650,765
Ensembl chr15:3,644,769...3,650,819
|
|
G |
Pnpla3 |
patatin-like phospholipase domain containing 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19946271 PMID:26482880 |
|
NCBI chr 7:125,034,760...125,056,165
Ensembl chr 7:125,034,764...125,055,976
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23274713 |
|
NCBI chr 1:220,992,770...221,003,249
Ensembl chr 1:220,992,770...221,003,249
|
|
G |
Serpine1 |
serpin family E member 1 |
susceptibility |
ISO |
DNA:polymorphism:promoter: |
RGD |
PMID:25987440 |
RGD:14696749 |
NCBI chr12:22,641,104...22,651,482
Ensembl chr12:22,641,104...22,651,482
|
|
G |
Serpinf1 |
serpin family F member 1 |
|
ISO |
protein:increased expression:serum (human) |
RGD |
PMID:27748324 |
RGD:27226704 |
NCBI chr10:62,241,750...62,254,145
Ensembl chr10:62,241,756...62,254,287
|
|
G |
Smad3 |
SMAD family member 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23274713 |
|
NCBI chr 8:68,569,530...68,678,349
Ensembl chr 8:68,569,530...68,678,349
|
|
G |
Sod2 |
superoxide dismutase 2 |
susceptibility |
ISO |
CTD Direct Evidence: marker/mechanism DNA:SNP: : 47T>C(human) |
CTD |
PMID:19731237, PMID:26873981 |
RGD:11060603 |
NCBI chr 1:47,914,757...47,921,587
Ensembl chr 1:47,914,759...47,921,587
|
|
G |
Tgfb1 |
transforming growth factor, beta 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23274713 |
|
NCBI chr 1:82,480,875...82,497,196
Ensembl chr 1:82,480,195...82,497,199
|
|
G |
Timp1 |
TIMP metallopeptidase inhibitor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23274713 |
|
NCBI chr X:1,364,771...1,369,451
Ensembl chr X:1,364,786...1,369,384
|
|
G |
Tlr9 |
toll-like receptor 9 |
|
ISO |
protein:increased expression:blood, neutrophil (human) |
RGD |
PMID:18433921 |
RGD:5130706 |
NCBI chr 8:114,916,122...114,920,171
Ensembl chr 8:114,916,122...114,920,171
|
|
G |
Tm6sf2 |
transmembrane 6 superfamily member 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26482880 |
|
NCBI chr16:21,092,483...21,099,695
Ensembl chr16:21,092,308...21,099,878
|
|
G |
Tnf |
tumor necrosis factor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23274713 |
|
NCBI chr20:5,189,382...5,192,000
Ensembl chr20:5,189,390...5,192,000
|
|
|
G |
Ace |
angiotensin I converting enzyme |
severity treatment |
ISO |
protein:increased activity:serum (human) |
RGD |
PMID:3028446, PMID:28691216 |
RGD:19165343, RGD:40400719 |
NCBI chr10:94,170,766...94,213,831
Ensembl chr10:94,170,766...94,187,822
|
|
G |
Adipor2 |
adiponectin receptor 2 |
treatment |
IEP |
|
RGD |
PMID:24797033 |
RGD:25824940 |
NCBI chr 4:151,412,135...151,480,108
Ensembl chr 4:151,414,684...151,428,894
|
|
G |
Aldh2 |
aldehyde dehydrogenase 2 family member |
susceptibility severity |
ISO |
DNA:missense mutation:cds, exon 12:p.E487K (human) DNA:polymorphism:exon 12: (human) DNA:deletion:cds: (mouse) |
RGD |
PMID:1916152, PMID:12198368, PMID:26173414, PMID:3189338 |
RGD:14696699, RGD:14981580, RGD:11076022, RGD:14696790 |
NCBI chr12:40,466,418...40,498,813
Ensembl chr12:40,466,495...40,498,752
|
|
G |
Angpt2 |
angiopoietin 2 |
severity |
ISO |
|
RGD |
PMID:24959006 |
RGD:15014784 |
NCBI chr16:75,966,480...76,016,147
Ensembl chr16:75,966,352...76,016,195
|
|
G |
C6 |
complement C6 |
resistance |
IAGP |
|
RGD |
PMID:15351314 |
RGD:1600673 |
NCBI chr 2:54,460,333...54,533,801
Ensembl chr 2:54,466,280...54,533,797
|
|
G |
Cav1 |
caveolin 1 |
treatment |
IEP |
|
RGD |
PMID:23764359 |
RGD:8662277 |
NCBI chr 4:44,597,123...44,630,206
Ensembl chr 4:44,597,123...44,630,200
|
|
G |
Cd27 |
CD27 molecule |
|
IEP |
|
RGD |
PMID:16698589 |
RGD:1581860 |
NCBI chr 4:157,744,881...157,751,609
Ensembl chr 4:157,744,882...157,750,088
|
|
G |
Cd59 |
CD59 molecule |
|
IEP |
protein:decreased expression:liver |
RGD |
PMID:12483994 |
RGD:1600486 |
NCBI chr 3:94,010,481...94,028,660
Ensembl chr 3:94,010,475...94,028,621
|
|
G |
Ctla4 |
cytotoxic T-lymphocyte-associated protein 4 |
susceptibility |
ISO |
DNA:SNP::-318 T>C(rs5742909)(human) |
RGD |
PMID:15208156 |
RGD:14398728 |
NCBI chr 9:67,699,397...67,706,068
Ensembl chr 9:67,699,379...67,706,065
|
|
G |
Cxcl1 |
C-X-C motif chemokine ligand 1 |
|
IEP |
mRNA:increased expression:liver |
RGD |
PMID:10498645 |
RGD:5135271 |
NCBI chr14:18,743,678...18,745,457
Ensembl chr14:18,743,685...18,745,457
|
|
G |
Cxcl2 |
C-X-C motif chemokine ligand 2 |
|
IEP |
mRNA:increased expression:liver |
RGD |
PMID:10498645 |
RGD:5135271 |
NCBI chr14:18,731,346...18,733,391
Ensembl chr14:18,731,378...18,733,391
|
|
G |
Cxcl6 |
C-X-C motif chemokine ligand 6 |
|
IEP |
mRNA:increased expression:liver |
RGD |
PMID:10498645 |
RGD:5135271 |
NCBI chr14:18,860,201...18,920,839
Ensembl chr14:18,860,264...18,862,407
|
|
G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
treatment |
ISO IEP |
|
RGD |
PMID:29401608, PMID:30192013, PMID:25592162, PMID:29902864 |
RGD:14700887, RGD:14700906, RGD:14700894, RGD:14700893 |
NCBI chr 1:213,511,892...213,522,195
Ensembl chr 1:213,511,874...213,535,542
|
|
G |
Egfr |
epidermal growth factor receptor |
|
ISO |
|
RGD |
PMID:30502657 |
RGD:38599215 |
NCBI chr14:99,919,485...100,104,136
Ensembl chr14:99,919,485...100,098,796
|
|
G |
Eif2s1 |
eukaryotic translation initiation factor 2 subunit alpha |
|
IDA |
|
RGD |
PMID:21059295 |
RGD:10395351 |
NCBI chr 6:102,048,372...102,073,041
Ensembl chr 6:102,048,372...102,073,041
|
|
G |
Fas |
Fas cell surface death receptor |
|
ISO |
protein:increased expression:lymphocyte: |
RGD |
PMID:26429926 |
RGD:14700711 |
NCBI chr 1:252,589,785...252,624,790
Ensembl chr 1:252,589,785...252,624,790
|
|
G |
Gstm1 |
glutathione S-transferase mu 1 |
|
ISO |
|
RGD |
PMID:15932176, PMID:26937962 |
RGD:14700973, RGD:11060494 |
NCBI chr 2:210,803,869...210,809,461
Ensembl chr 2:210,803,869...210,809,306
|
|
G |
Gstt1 |
glutathione S-transferase theta 1 |
|
ISO |
|
RGD |
PMID:15932176, PMID:26937962 |
RGD:14700973, RGD:11060494 |
NCBI chr20:13,799,102...13,816,527
Ensembl chr20:13,799,102...13,816,526
|
|
G |
Hfe |
homeostatic iron regulator |
|
IEP |
mRNA:increased expression:liver, Kupffer cell (rat) |
RGD |
PMID:18599584 |
RGD:8694397 |
NCBI chr17:43,661,276...43,669,327
Ensembl chr17:43,661,222...43,669,985
|
|
G |
Hif1a |
hypoxia inducible factor 1 subunit alpha |
|
IEP |
mRNA:increased expression:liver (rat) |
RGD |
PMID:17085342 |
RGD:9068897 |
NCBI chr 6:96,810,868...96,856,303
Ensembl chr 6:96,810,907...96,856,052
|
|
G |
Igf2 |
insulin-like growth factor 2 |
|
IEP |
mRNA:increased expression:liver |
RGD |
PMID:18505416 |
RGD:5510002 |
NCBI chr 1:215,828,102...215,839,081
Ensembl chr 1:215,828,102...215,846,911
|
|
G |
Il1b |
interleukin 1 beta |
|
IEP |
protein:increased expression:serum (rat) |
RGD |
PMID:23009062 |
RGD:7204488 |
NCBI chr 3:121,876,256...121,882,637
Ensembl chr 3:121,876,263...121,882,726
|
|
G |
Keap1 |
Kelch-like ECH-associated protein 1 |
|
ISO |
mRNA:decreased expression:liver (human) |
RGD |
PMID:22459801 |
RGD:6892954 |
NCBI chr 8:22,250,518...22,259,868
Ensembl chr 8:22,250,518...22,259,779
|
|
G |
Lpl |
lipoprotein lipase |
treatment |
IEP |
|
RGD |
PMID:28442378 |
RGD:13794376 |
NCBI chr16:22,537,687...22,561,487
Ensembl chr16:22,537,056...22,561,496
|
|
G |
Mif |
macrophage migration inhibitory factor |
|
IEP |
protein:increased expression:liver |
RGD |
PMID:11798463 |
RGD:1642007 |
NCBI chr20:13,715,219...13,732,980
Ensembl chr20:13,732,198...13,732,859
|
|
G |
Mir122 |
microRNA 122 |
|
ISO |
miRNA:decreased expression:hepatocyte |
RGD |
PMID:28987423 |
RGD:14401600 |
NCBI chr18:60,755,285...60,755,369
|
|
G |
Mir155 |
microRNA 155 |
|
ISO |
|
RGD |
PMID:28492308 |
RGD:25314298 |
NCBI chr11:24,176,603...24,176,667
Ensembl chr11:24,176,603...24,176,667
|
|
G |
Mir223 |
microRNA 223 |
severity |
ISO |
|
RGD |
PMID:27679493 |
RGD:21408575 |
NCBI chr X:65,367,812...65,367,921
Ensembl chr X:65,367,812...65,367,921
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
|
IEP |
protein:increased expression:liver |
RGD |
PMID:17374579 |
RGD:1642042 |
NCBI chr 3:161,413,410...161,421,473
Ensembl chr 3:161,413,298...161,421,520
|
|
G |
Myc |
MYC proto-oncogene, bHLH transcription factor |
disease_progression severity |
ISO |
mRNA:increased expression:liver |
RGD |
PMID:26576483, PMID:26576483 |
RGD:14695016, RGD:14695016 |
NCBI chr 7:102,586,313...102,591,240
Ensembl chr 7:102,586,313...102,591,240
|
|
G |
Nedd8 |
NEDD8 ubiquitin like modifier |
|
ISO |
|
RGD |
PMID:12533840 |
RGD:1549458 |
NCBI chr15:34,340,607...34,352,673
Ensembl chr15:34,340,607...34,352,673
|
|
G |
Nfe2l2 |
nuclear factor, erythroid 2-like 2 |
treatment severity |
ISO |
DNA:SNP:promoter:rs35652124(human) |
RGD |
PMID:31906014, PMID:31340446 |
RGD:21201307, RGD:21201311 |
NCBI chr 3:62,497,568...62,525,146
Ensembl chr 3:62,497,571...62,524,996
|
|
G |
Otc |
ornithine transcarbamylase |
|
IEP |
protein:increased expression:serum (rat) |
RGD |
PMID:19101528 |
RGD:4144059 |
NCBI chr X:13,524,804...13,601,074
Ensembl chr X:13,524,607...13,601,069
|
|
G |
Plaur |
plasminogen activator, urokinase receptor |
|
ISO |
protein:increased expression:serum |
RGD |
PMID:22098627 |
RGD:6484116 |
NCBI chr 1:81,328,171...81,344,954
Ensembl chr 1:81,328,183...81,344,708
|
|
G |
Pnpla3 |
patatin-like phospholipase domain containing 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19946271 |
|
NCBI chr 7:125,034,760...125,056,165
Ensembl chr 7:125,034,764...125,055,976
|
|
G |
Ppara |
peroxisome proliferator activated receptor alpha |
severity |
ISO |
DNA:knockout::increased severity in knockouts (mouse) |
RGD |
PMID:15382117 |
RGD:5683636 |
NCBI chr 7:126,618,872...126,687,282
Ensembl chr 7:126,619,196...126,681,752
|
|
G |
Ppard |
peroxisome proliferator-activated receptor delta |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27765815 |
|
NCBI chr20:7,818,289...7,883,482
Ensembl chr20:7,818,289...7,885,333
|
|
G |
Psmd14 |
proteasome 26S subunit, non-ATPase 14 |
|
IEP |
protein:decreased expression:liver, cytosolic proteasome complex (rat) |
RGD |
PMID:19609968 |
RGD:9480236 |
NCBI chr 3:47,578,449...47,673,330
Ensembl chr 3:47,578,384...47,673,338
|
|
G |
Rbp4 |
retinol binding protein 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16762690 |
|
NCBI chr 1:256,806,476...256,813,678
Ensembl chr 1:256,806,472...256,813,711
|
|
G |
Slc39a13 |
solute carrier family 39 member 13 |
|
IEP |
protein:increased expression:liver, endoplasmic reticulum (rat) |
RGD |
PMID:25767260 |
RGD:11553884 |
NCBI chr 3:79,884,524...79,892,664
Ensembl chr 3:79,884,524...79,892,429
|
|
G |
Sod1 |
superoxide dismutase 1 |
treatment |
ISO |
human gene in a rat model |
RGD |
PMID:11266387 |
RGD:9587792 |
NCBI chr11:30,363,282...30,368,858
Ensembl chr11:30,363,280...30,368,862
|
|
G |
Sod2 |
superoxide dismutase 2 |
treatment |
ISO |
|
RGD |
PMID:32236798 |
RGD:27095880 |
NCBI chr 1:47,914,757...47,921,587
Ensembl chr 1:47,914,759...47,921,587
|
|
G |
Spp1 |
secreted phosphoprotein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18703563 |
|
NCBI chr14:6,673,686...6,679,965
Ensembl chr14:6,673,686...6,679,901
|
|
G |
Tbxas1 |
thromboxane A synthase 1 |
|
IEP |
mRNA,protein:increased expression:liver, Kupffer cell: |
RGD |
PMID:9262373 |
RGD:11059607 |
NCBI chr 4:66,624,181...66,846,745
Ensembl chr 4:66,670,618...66,846,805
|
|
G |
Tert |
telomerase reverse transcriptase |
|
ISO |
mRNA,protein,activity:increased expression, increased activity:kupffer cell: |
RGD |
PMID:26725521 |
RGD:11574970 |
NCBI chr 1:32,250,876...32,275,330
Ensembl chr 1:32,251,714...32,272,476
|
|
G |
Tlr3 |
toll-like receptor 3 |
treatment |
ISO |
|
RGD |
PMID:23023014, PMID:30870678 |
RGD:21079426, RGD:21079436 |
NCBI chr16:50,016,466...50,031,011
Ensembl chr16:50,016,857...50,031,214
|
|
G |
Tnf |
tumor necrosis factor |
treatment |
IMP IEP |
mRNA:increased expression:liver (rat) |
RGD |
PMID:9397994, PMID:7556590, PMID:15670576 |
RGD:14398736, RGD:14995472, RGD:14995456 |
NCBI chr20:5,189,382...5,192,000
Ensembl chr20:5,189,390...5,192,000
|
|
G |
Uchl5 |
ubiquitin C-terminal hydrolase L5 |
|
IEP |
protein:decreased expression:liver, cytosolic proteasome complex |
RGD |
PMID:19609968 |
RGD:9480236 |
NCBI chr13:60,568,102...60,603,812
Ensembl chr13:60,545,635...60,603,811
|
|
G |
Vegfa |
vascular endothelial growth factor A |
|
ISO |
protein:increased expression:plasma |
RGD |
PMID:24959006 |
RGD:15014784 |
NCBI chr 9:17,340,341...17,355,681
Ensembl chr 9:17,340,341...17,355,681
|
|
|
G |
Igf1 |
insulin-like growth factor 1 |
|
IEP |
|
RGD |
PMID:23016131 |
RGD:10402569 |
NCBI chr 7:28,412,123...28,491,815
Ensembl chr 7:28,412,198...28,486,609
|
|
G |
Igf1r |
insulin-like growth factor 1 receptor |
|
IEP |
|
RGD |
PMID:23016131 |
RGD:10402569 |
NCBI chr 1:128,924,921...129,213,816
Ensembl chr 1:128,924,966...129,206,516
|
|
G |
Igf2 |
insulin-like growth factor 2 |
|
IEP |
|
RGD |
PMID:23016131 |
RGD:10402569 |
NCBI chr 1:215,828,102...215,839,081
Ensembl chr 1:215,828,102...215,846,911
|
|
|
G |
Cftr |
CF transmembrane conductance regulator |
|
ISO |
DNA:missense mutations: :p.L1156F, Q1352H (human) |
RGD |
PMID:26089335 |
RGD:11566036 |
NCBI chr 4:42,693,263...42,860,679
Ensembl chr 4:42,692,836...42,860,676
|
|
G |
Pthlh |
parathyroid hormone-like hormone |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22280800 |
|
NCBI chr 4:181,663,425...181,674,181
|
|
G |
Ugt1a7c |
UDP glucuronosyltransferase 1 family, polypeptide A7C |
|
ISO |
DNA:polymorphisms: :p.N129K, p.R131K, p.W208R (human) |
RGD |
PMID:12806614 |
RGD:2317503 |
NCBI chr 9:95,233,957...95,302,822
Ensembl chr 9:95,161,157...95,302,822
|
|
|
G |
Ache |
acetylcholinesterase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16470869 |
|
NCBI chr12:22,472,358...22,477,052
Ensembl chr12:22,472,358...22,478,753
|
|
G |
Acsl6 |
acyl-CoA synthetase long-chain family member 6 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18316681 |
|
NCBI chr10:39,654,771...39,717,592
Ensembl chr10:39,655,455...39,719,312
|
|
G |
Adora2a |
adenosine A2a receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20799992 |
|
NCBI chr20:14,265,251...14,282,873
Ensembl chr20:14,265,252...14,282,873
|
|
G |
Ak5 |
adenylate kinase 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18316681 |
|
NCBI chr 2:257,671,772...257,864,385
Ensembl chr 2:257,671,772...257,864,385
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15982448 |
|
NCBI chr 6:137,218,398...137,239,970
Ensembl chr 6:137,218,376...137,236,258
|
|
G |
Aoah |
acyloxyacyl hydrolase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18316681 |
|
NCBI chr17:45,872,414...46,115,026
Ensembl chr17:45,872,414...46,115,004
|
|
G |
Arrb2 |
arrestin, beta 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17233643 |
|
NCBI chr10:57,040,252...57,048,045
Ensembl chr10:57,040,267...57,048,134
|
|
G |
Astn2 |
astrotactin 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18316681 |
|
NCBI chr 5:81,179,614...82,168,528
Ensembl chr 5:81,179,605...82,168,427
|
|
G |
Bdnf |
brain-derived neurotrophic factor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20736000 |
|
NCBI chr 3:100,768,637...100,819,216
Ensembl chr 3:100,768,637...100,819,210
|
|
G |
Cchcr1 |
coiled-coil alpha-helical rod protein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18316681 |
|
NCBI chr20:3,730,968...3,745,721
Ensembl chr20:3,730,955...3,740,009
|
|
G |
Cd55 |
CD55 molecule (Cromer blood group) |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18316681 |
|
NCBI chr13:47,125,156...47,153,557
Ensembl chr13:47,126,741...47,154,292
|
|
G |
Cdh13 |
cadherin 13 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18316681 |
|
NCBI chr19:50,848,793...51,971,618
Ensembl chr19:50,848,736...51,972,103
|
|
G |
Cfh |
complement factor H |
|
ISO IEP |
protein:increased expression:serum: protein:increased expression:serum, hippocampus: |
RGD |
PMID:22871478, PMID:22871478 |
RGD:7364944, RGD:7364944 |
NCBI chr13:56,979,155...57,080,540
Ensembl chr13:56,978,607...57,080,622
|
|
G |
Col28a1 |
collagen type XXVIII alpha 1 chain |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18316681 |
|
NCBI chr 4:34,048,074...34,198,558
Ensembl chr 4:34,048,533...34,194,764
|
|
G |
Comt |
catechol-O-methyltransferase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15274053 |
|
NCBI chr11:86,715,981...86,735,630
Ensembl chr11:86,715,981...86,735,622
|
|
G |
Csmd1 |
CUB and Sushi multiple domains 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18316681 |
|
NCBI chr16:77,152,823...78,850,222
Ensembl chr16:78,539,489...78,850,222
|
|
G |
Cubn |
cubilin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18316681 |
|
NCBI chr17:80,584,921...80,807,181
Ensembl chr17:80,584,878...80,807,243
|
|
G |
Cyp2d4 |
cytochrome P450, family 2, subfamily d, polypeptide 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18280655 |
|
NCBI chr 7:123,599,264...123,608,436
Ensembl chr 7:123,599,266...123,608,436
|
|
G |
Dcstamp |
dendrocyte expressed seven transmembrane protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18316681 |
|
NCBI chr 7:78,642,016...78,651,763
Ensembl chr 7:78,649,875...78,650,906
|
|
G |
Drd1 |
dopamine receptor D1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18363855 PMID:19444617 |
|
NCBI chr17:11,099,736...11,104,352
Ensembl chr17:11,101,306...11,103,541
|
|
G |
Drd2 |
dopamine receptor D2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18363855 PMID:18555060 PMID:19940168 |
|
NCBI chr 8:53,678,777...53,743,643
Ensembl chr 8:53,678,777...53,743,642
|
|
G |
Drd3 |
dopamine receptor D3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19940168 |
|
NCBI chr11:61,819,102...61,883,223
Ensembl chr11:61,822,077...61,874,327
|
|
G |
Drd4 |
dopamine receptor D4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15274053 |
|
NCBI chr 1:214,278,296...214,282,818
Ensembl chr 1:214,278,296...214,281,483
|
|
G |
Ephx1 |
epoxide hydrolase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19598248 |
|
NCBI chr13:99,271,390...99,300,580
Ensembl chr13:99,271,366...99,300,579
|
|
G |
Fhit |
fragile histidine triad diadenosine triphosphatase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18316681 |
|
NCBI chr15:15,697,292...16,862,873
|
|
G |
Fkbp15 |
FKBP prolyl isomerase family member 15 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18316681 |
|
NCBI chr 5:78,133,357...78,229,311
Ensembl chr 5:78,133,886...78,183,122
|
|
G |
Fos |
Fos proto-oncogene, AP-1 transcription factor subunit |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19689456 |
|
NCBI chr 6:109,300,433...109,303,299
Ensembl chr 6:109,300,433...109,303,299
|
|
G |
Gabrg2 |
gamma-aminobutyric acid type A receptor subunit gamma 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15772696 |
|
NCBI chr10:27,090,913...27,179,786
Ensembl chr10:27,092,827...27,179,900
|
|
G |
Gdnf |
glial cell derived neurotrophic factor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17356005 |
|
NCBI chr 2:56,884,181...56,912,964
Ensembl chr 2:56,887,987...56,910,238
|
|
G |
Grm2 |
glutamate metabotropic receptor 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20211215 |
|
NCBI chr 8:115,344,999...115,358,628
Ensembl chr 8:115,344,999...115,358,046
|
|
G |
Gstm1 |
glutathione S-transferase mu 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19254865 |
|
NCBI chr 2:210,803,869...210,809,461
Ensembl chr 2:210,803,869...210,809,306
|
|
G |
Gstp1 |
glutathione S-transferase pi 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15729709 |
|
NCBI chr 1:219,291,679...219,294,147
Ensembl chr 1:219,291,679...219,294,147
|
|
G |
Gstt1 |
glutathione S-transferase theta 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18186040 PMID:19254865 |
|
NCBI chr20:13,799,102...13,816,527
Ensembl chr20:13,799,102...13,816,526
|
|
G |
Hdac8 |
histone deacetylase 8 |
|
IEP |
mRNA:decreased expression:striatum (rat) |
RGD |
PMID:25452209 |
RGD:9681719 |
NCBI chr X:72,163,777...72,370,058
Ensembl chr X:72,163,777...72,370,044
|
|
G |
Hs3st4 |
heparan sulfate-glucosamine 3-sulfotransferase 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18316681 |
|
NCBI chr 1:193,834,007...194,240,806
|
|
G |
Htr1b |
5-hydroxytryptamine receptor 1B |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:10780831 |
|
NCBI chr 8:89,113,984...89,130,830
Ensembl chr 8:89,129,453...89,130,991
|
|
G |
Htr3a |
5-hydroxytryptamine receptor 3A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19689456 |
|
NCBI chr 8:53,211,436...53,223,878
Ensembl chr 8:53,211,438...53,223,804
|
|
G |
Htr6 |
5-hydroxytryptamine receptor 6 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20705401 |
|
NCBI chr 5:157,501,202...157,518,870
Ensembl chr 5:157,503,040...157,518,631
|
|
G |
Large1 |
LARGE xylosyl- and glucuronyltransferase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18316681 |
|
NCBI chr19:12,481,563...12,945,320
Ensembl chr19:12,481,540...12,942,963
|
|
G |
Lingo2 |
leucine rich repeat and Ig domain containing 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18316681 |
|
NCBI chr 5:51,466,367...51,638,161
|
|
G |
Map2k5 |
mitogen activated protein kinase kinase 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18316681 |
|
NCBI chr 8:68,055,976...68,282,656
Ensembl chr 8:68,055,972...68,282,590
|
|
G |
Mtarc1 |
mitochondrial amidoxime reducing component 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18316681 |
|
NCBI chr13:102,693,679...102,724,120
Ensembl chr13:102,698,546...102,721,218
|
|
G |
Mtarc2 |
mitochondrial amidoxime reducing component 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18316681 |
|
NCBI chr13:102,724,266...102,755,511
Ensembl chr13:102,724,348...102,756,174
|
|
G |
Myo5b |
myosin Vb |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18316681 |
|
NCBI chr18:70,426,865...70,729,985
Ensembl chr18:70,427,007...70,729,030
|
|
G |
Nos1 |
nitric oxide synthase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15542708 |
|
NCBI chr12:44,214,949...44,405,530
Ensembl chr12:44,213,943...44,520,341
|
|
G |
Npy1r |
neuropeptide Y receptor Y1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19566775 |
|
NCBI chr16:24,779,480...24,789,131
Ensembl chr16:24,779,477...24,788,740
|
|
G |
Nrg1 |
neuregulin 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18316681 |
|
NCBI chr16:62,969,573...64,065,063
Ensembl chr16:63,837,216...64,057,434
|
|
G |
Oprm1 |
opioid receptor, mu 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16402083 |
|
NCBI chr 1:43,454,803...43,704,948
Ensembl chr 1:43,454,803...43,704,948
|
|
G |
PCOLCE2 |
procollagen C-endopeptidase enhancer 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18316681 |
|
NCBI chr 8:103,459,219...103,484,557
Ensembl chr 8:103,459,161...103,484,535
|
|
G |
Pde4b |
phosphodiesterase 4B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18316681 |
|
NCBI chr 5:121,759,236...122,136,814
Ensembl chr 5:121,952,977...122,136,814
|
|
G |
Pde4d |
phosphodiesterase 4D |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18316681 |
|
NCBI chr 2:40,219,999...41,468,551
Ensembl chr 2:40,554,146...41,464,264
|
|
G |
Pde6c |
phosphodiesterase 6C |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18316681 |
|
NCBI chr 1:256,822,099...256,885,879
Ensembl chr 1:256,822,334...256,877,810
|
|
G |
Pdyn |
prodynorphin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16529859 |
|
NCBI chr 3:122,194,327...122,206,671
Ensembl chr 3:122,194,329...122,206,671
|
|
G |
Pick1 |
protein interacting with PRKCA 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17606663 |
|
NCBI chr 7:120,465,472...120,484,824
Ensembl chr 7:120,465,130...120,484,840
|
|
G |
Plat |
plasminogen activator, tissue type |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15659235 |
|
NCBI chr16:74,098,263...74,122,897
Ensembl chr16:74,098,260...74,122,889
|
|
G |
Pou5f1 |
POU class 5 homeobox 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18316681 |
|
NCBI chr20:3,747,231...3,751,994
Ensembl chr20:3,747,221...3,751,994
|
|
G |
Prdm2 |
PR/SET domain 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18316681 |
|
NCBI chr 5:161,769,587...161,879,150
Ensembl chr 5:161,770,653...161,879,133
|
|
G |
Prkg1 |
protein kinase cGMP-dependent 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18316681 |
|
NCBI chr 1:248,982,039...250,300,952
|
|
G |
Prokr2 |
prokineticin receptor 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20576534 |
|
NCBI chr 3:125,006,180...125,021,020
Ensembl chr 3:125,009,260...125,017,377
|
|
G |
Psd3 |
pleckstrin and Sec7 domain containing 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18316681 |
|
NCBI chr16:23,212,165...23,789,414
Ensembl chr16:23,447,366...23,781,604
|
|
G |
Raly |
RALY heterogeneous nuclear ribonucleoprotein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18316681 |
|
NCBI chr 3:150,322,834...150,387,345
Ensembl chr 3:150,323,116...150,387,332
|
|
G |
Rapgef5 |
Rap guanine nucleotide exchange factor 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18316681 |
|
NCBI chr 6:145,387,890...145,625,243
Ensembl chr 6:145,546,595...145,625,236
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19689456 |
|
NCBI chr 1:220,992,770...221,003,249
Ensembl chr 1:220,992,770...221,003,249
|
|
G |
Rgs17 |
regulator of G-protein signaling 17 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18316681 |
|
NCBI chr 1:42,491,566...42,587,735
Ensembl chr 1:42,492,761...42,587,721
|
|
G |
Serpina5 |
serpin family A member 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18316681 |
|
NCBI chr 6:127,753,152...127,772,403
Ensembl chr 6:127,766,470...127,772,420
|
|
G |
Sgcz |
sarcoglycan zeta |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18316681 |
|
NCBI chr16:57,136,433...58,206,350
|
|
G |
Sh3rf3 |
SH3 domain containing ring finger 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18316681 |
|
NCBI chr20:28,355,671...28,720,020
Ensembl chr20:28,572,242...28,717,243
|
|
G |
Slc6a3 |
solute carrier family 6 member 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12931138 |
|
NCBI chr 1:32,323,011...32,363,983
Ensembl chr 1:32,321,580...32,363,983
|
|
G |
Slc6a4 |
solute carrier family 6 member 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19689456 |
|
NCBI chr10:63,153,656...63,188,377
Ensembl chr10:63,153,651...63,176,463
|
|
G |
Slc6a9 |
solute carrier family 6 member 9 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17582620 |
|
NCBI chr 5:136,669,674...136,703,702
Ensembl chr 5:136,669,674...136,703,697
|
|
G |
Smyd3 |
SET and MYND domain containing 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18316681 |
|
NCBI chr13:97,330,120...97,807,813
|
|
G |
Snca |
synuclein alpha |
treatment |
IMP ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15542733 PMID:32278788, PMID:20551914 |
RGD:13506280 |
NCBI chr 4:90,782,412...90,883,236
Ensembl chr 4:90,782,374...90,882,285
|
|
G |
Trpm3 |
transient receptor potential cation channel, subfamily M, member 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18316681 |
|
NCBI chr 1:239,741,572...240,757,583
Ensembl chr 1:240,355,149...240,757,583
|
|
G |
Usp48 |
ubiquitin specific peptidase 48 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18316681 |
|
NCBI chr 5:155,935,102...156,002,722
Ensembl chr 5:155,934,490...156,002,721
|
|
G |
Zfp385d |
zinc finger protein 385D |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18316681 |
|
NCBI chr15:6,200,825...7,249,168
Ensembl chr15:6,200,829...6,587,367
|
|
G |
Zfp423 |
zinc finger protein 423 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18316681 |
|
NCBI chr19:20,147,201...20,405,999
Ensembl chr19:20,147,037...20,406,003
|
|
|
G |
Abcb1a |
ATP binding cassette subfamily B member 1A |
susceptibility |
ISO |
DNA:missense mutation:cds:p.G671V (human) |
RGD |
PMID:16330681 |
RGD:11041175 |
NCBI chr 4:22,339,829...22,517,642
Ensembl chr 4:22,133,521...22,425,515
|
|
G |
Capn2 |
calpain 2 |
treatment |
IEP |
|
RGD |
PMID:25634181 |
RGD:13792617 |
NCBI chr13:100,878,649...100,928,811
Ensembl chr13:100,878,650...100,928,811
|
|
G |
Ercc2 |
ERCC excision repair 2, TFIIH core complex helicase subunit |
|
ISO |
associated with Leukemia, Myeloid, Acute;DNA:SNP:exon:p.K751Q (rs13181) (human) |
RGD |
PMID:24284041 |
RGD:11252190 |
NCBI chr 1:80,293,574...80,307,334
Ensembl chr 1:80,293,566...80,307,344
|
|
|
G |
Akap9 |
A-kinase anchoring protein 9 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16835338 |
|
NCBI chr 4:27,195,346...27,331,582
Ensembl chr 4:27,195,346...27,331,582
|
|
G |
Alad |
aminolevulinate dehydratase |
|
IEP |
protein:decreased activity:blood (rat) |
RGD |
PMID:19022878 |
RGD:4144202 |
NCBI chr 5:78,368,867...78,379,206
Ensembl chr 5:78,368,867...78,379,346
|
|
G |
Aqp9 |
aquaporin 9 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19805235 |
|
NCBI chr 8:77,559,621...77,599,781
Ensembl chr 8:77,559,624...77,599,781
|
|
G |
As3mt |
arsenite methyltransferase |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:21447609 PMID:26366667 |
|
NCBI chr 1:266,482,787...266,514,570
Ensembl chr 1:266,482,858...266,514,569
|
|
G |
Atxn7 |
ataxin 7 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16835338 |
|
NCBI chr15:12,421,432...12,569,649
Ensembl chr15:12,425,175...12,513,931
|
|
G |
Ccl20 |
C-C motif chemokine ligand 20 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16835338 |
|
NCBI chr 9:88,918,359...88,921,017
Ensembl chr 9:88,918,433...88,921,001
|
|
G |
Ccl4 |
C-C motif chemokine ligand 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16835338 |
|
NCBI chr10:70,870,926...70,886,357
Ensembl chr10:70,884,531...70,886,355
|
|
G |
Ccrl2 |
C-C motif chemokine receptor like 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16835338 |
|
NCBI chr 8:119,324,298...119,326,954
Ensembl chr 8:119,324,613...119,326,938
|
|
G |
Cd44 |
CD44 molecule (Indian blood group) |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16835338 |
|
NCBI chr 3:92,695,083...92,783,820
Ensembl chr 3:92,696,313...92,783,658
|
|
G |
Cd83 |
CD83 molecule |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16835338 |
|
NCBI chr17:24,416,651...24,435,790
Ensembl chr17:24,416,651...24,435,790
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
ISO |
protein:increased expression:skin: |
RGD |
PMID:11860939 |
RGD:8662429 |
NCBI chr20:6,348,422...6,358,864
Ensembl chr20:6,351,458...6,358,864
|
|
G |
Crp |
C-reactive protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22521605 |
|
NCBI chr13:91,080,448...91,081,358
Ensembl chr13:91,054,974...91,093,713
|
|
G |
Cxcl2 |
C-X-C motif chemokine ligand 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16835338 |
|
NCBI chr14:18,731,346...18,733,391
Ensembl chr14:18,731,378...18,733,391
|
|
G |
Ercc1 |
ERCC excision repair 1, endonuclease non-catalytic subunit |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12569548 |
|
NCBI chr 1:80,256,973...80,268,198
Ensembl chr 1:80,256,973...80,268,198
|
|
G |
Ercc3 |
ERCC excision repair 3, TFIIH core complex helicase subunit |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12569548 |
|
NCBI chr18:25,037,668...25,068,380
Ensembl chr18:25,037,625...25,068,389
|
|
G |
Ercc4 |
ERCC excision repair 4, endonuclease catalytic subunit |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12569548 |
|
NCBI chr10:2,010,140...2,037,953
Ensembl chr10:2,010,648...2,037,891
|
|
G |
Gadd45b |
growth arrest and DNA-damage-inducible, beta |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16835338 |
|
NCBI chr 7:11,646,283...11,648,338
Ensembl chr 7:11,646,269...11,648,322
|
|
G |
Golga4 |
golgin A4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16835338 |
|
NCBI chr 8:127,171,221...127,248,938
Ensembl chr 8:127,171,537...127,248,538
|
|
G |
Gsr |
glutathione-disulfide reductase |
|
IEP |
|
RGD |
PMID:25209654 |
RGD:10401880 |
NCBI chr16:62,197,617...62,239,987
Ensembl chr16:62,197,617...62,241,361
|
|
G |
Hspa1b |
heat shock protein family A (Hsp70) member 1B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16835338 |
|
NCBI chr20:4,877,638...4,880,112
Ensembl chr20:2,699,712...2,701,815
|
|
G |
Id2 |
inhibitor of DNA binding 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16835338 |
|
NCBI chr 6:44,360,077...44,361,908
Ensembl chr 6:44,348,501...44,363,915
|
|
G |
Ier3 |
immediate early response 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16835338 |
|
NCBI chr20:3,438,798...3,440,002
Ensembl chr20:3,438,798...3,440,769
|
|
G |
Il1a |
interleukin 1 alpha |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16835338 |
|
NCBI chr 3:121,824,712...121,836,122
Ensembl chr 3:121,825,412...121,836,086
|
|
G |
Il1b |
interleukin 1 beta |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16835338 |
|
NCBI chr 3:121,876,256...121,882,637
Ensembl chr 3:121,876,263...121,882,726
|
|
G |
Il1rn |
interleukin 1 receptor antagonist |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16835338 |
|
NCBI chr 3:1,449,778...1,468,624
Ensembl chr 3:1,452,644...1,468,614
|
|
G |
Inpp5a |
inositol polyphosphate-5-phosphatase A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25759212 |
|
NCBI chr 1:211,732,163...211,920,844
Ensembl chr 1:211,732,713...211,921,099
|
|
G |
Kcnj2 |
potassium inwardly-rectifying channel, subfamily J, member 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16835338 |
|
NCBI chr10:99,429,337...99,442,520
Ensembl chr10:99,437,436...99,439,114
|
|
G |
Krt10 |
keratin 10 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19953893 |
|
NCBI chr10:87,296,445...87,301,307
Ensembl chr10:87,296,451...87,300,736
|
|
G |
Minpp1 |
multiple inositol-polyphosphate phosphatase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16835338 |
|
NCBI chr 1:251,045,352...251,071,045
Ensembl chr 1:251,045,440...251,071,040
|
|
G |
Mir145 |
microRNA 145 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29705342 |
|
NCBI chr18:56,969,907...56,969,994
Ensembl chr18:56,969,907...56,969,994
|
|
G |
Mir155 |
microRNA 155 |
|
ISO |
miRNA:increased expression:serum |
RGD |
PMID:27913196 |
RGD:25314296 |
NCBI chr11:24,176,603...24,176,667
Ensembl chr11:24,176,603...24,176,667
|
|
G |
Mt1 |
metallothionein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19953893 |
|
NCBI chr19:11,301,991...11,303,007
Ensembl chr17:78,793,336...78,793,724
|
|
G |
Mthfr |
methylenetetrahydrofolate reductase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24384392 |
|
NCBI chr 5:164,844,642...164,864,360
Ensembl chr 5:164,845,925...164,860,910
|
|
G |
N4bp2l2 |
NEDD4 binding protein 2-like 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16835338 |
|
NCBI chr12:627,128...650,604
Ensembl chr12:628,488...650,376
|
|
G |
Ndufb8 |
NADH:ubiquinone oxidoreductase subunit B8 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16835338 |
|
NCBI chr 1:264,298,671...264,303,712
Ensembl chr 1:264,298,669...264,303,762
|
|
G |
Nr4a2 |
nuclear receptor subfamily 4, group A, member 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16835338 |
|
NCBI chr 3:43,111,258...43,128,391
Ensembl chr 3:43,111,240...43,119,159
|
|
G |
Pde4b |
phosphodiesterase 4B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16835338 |
|
NCBI chr 5:121,759,236...122,136,814
Ensembl chr 5:121,952,977...122,136,814
|
|
G |
Peli1 |
pellino E3 ubiquitin protein ligase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16835338 |
|
NCBI chr14:106,008,086...106,062,566
Ensembl chr14:106,008,086...106,061,641
|
|
G |
Pfkfb3 |
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16835338 |
|
NCBI chr17:70,632,778...70,713,736
Ensembl chr17:70,684,134...70,713,726
|
|
G |
Pias1 |
protein inhibitor of activated STAT, 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16835338 |
|
NCBI chr 8:67,771,720...67,869,015
Ensembl chr 8:67,771,720...67,869,019
|
|
G |
Pnp |
purine nucleoside phosphorylase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18414634 |
|
NCBI chr15:27,875,883...27,883,566
Ensembl chr15:27,875,911...27,883,350
|
|
G |
Ptx3 |
pentraxin 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16835338 |
|
NCBI chr 2:158,097,843...158,103,653
Ensembl chr 2:158,097,843...158,103,653
|
|
G |
Rfx3 |
regulatory factor X3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16835338 |
|
NCBI chr 1:245,853,332...246,110,648
Ensembl chr 1:245,859,633...246,110,218
|
|
G |
Rgs1 |
regulator of G-protein signaling 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16835338 |
|
NCBI chr13:61,066,196...61,070,772
Ensembl chr13:61,066,153...61,070,599
|
|
G |
Rnf20 |
ring finger protein 20 |
|
ISO |
protein:increased expression:urine (human) |
RGD |
PMID:21136906 |
RGD:9831407 |
NCBI chr 5:64,892,996...64,920,397
Ensembl chr 5:64,892,802...64,920,390
|
|
G |
Rufy3 |
RUN and FYVE domain containing 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16835338 |
|
NCBI chr14:21,058,575...21,144,775
Ensembl chr14:21,058,595...21,128,505
|
|
G |
Sfpq |
splicing factor proline and glutamine rich |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16835338 |
|
NCBI chr 5:145,079,803...145,088,517
Ensembl chr 5:145,079,803...145,088,498
|
|
G |
Skil |
SKI-like proto-oncogene |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16835338 |
|
NCBI chr 2:115,862,932...115,891,304
Ensembl chr 2:115,866,701...115,891,097
|
|
G |
Sod2 |
superoxide dismutase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16835338 |
|
NCBI chr 1:47,914,757...47,921,587
Ensembl chr 1:47,914,759...47,921,587
|
|
G |
Sox18 |
SRY-box transcription factor 18 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16835338 |
|
NCBI chr 3:177,177,237...177,179,039
Ensembl chr 3:177,177,310...177,179,127
|
|
G |
Srp68 |
signal recognition particle 68 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16835338 |
|
NCBI chr10:105,123,324...105,150,080
Ensembl chr10:105,123,327...105,228,547
|
|
G |
Ssbp1 |
single stranded DNA binding protein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16835338 |
|
NCBI chr 4:68,634,844...68,645,112
Ensembl chr 4:68,634,929...68,645,172
|
|
G |
Taf1d |
TATA-box binding protein associated factor, RNA polymerase I subunit D |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16835338 |
|
NCBI chr 8:13,861,242...13,871,508
Ensembl chr 8:13,861,459...13,871,354
|
|
G |
Tnf |
tumor necrosis factor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16835338 |
|
NCBI chr20:5,189,382...5,192,000
Ensembl chr20:5,189,390...5,192,000
|
|
G |
Tnfaip6 |
TNF alpha induced protein 6 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16835338 |
|
NCBI chr 3:37,545,238...37,564,704
Ensembl chr 3:37,545,238...37,564,699
|
|
G |
Tnik |
TRAF2 and NCK interacting kinase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16835338 |
|
NCBI chr 2:113,984,599...114,391,805
Ensembl chr 2:113,984,646...114,384,894
|
|
G |
Tp53 |
tumor protein p53 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18621066 PMID:19203779 |
|
NCBI chr10:56,186,299...56,198,449
Ensembl chr10:56,187,020...56,198,449
|
|
G |
Tra2a |
transformer 2 alpha homolog |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16835338 |
|
NCBI chr 4:78,905,380...78,924,203
Ensembl chr 4:78,905,380...78,924,181
|
|
G |
Trappc10 |
trafficking protein particle complex subunit 10 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16835338 |
|
NCBI chr20:11,168,298...11,228,634
Ensembl chr20:11,168,298...11,228,625
|
|
G |
Ube2e1 |
ubiquitin-conjugating enzyme E2E 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16835338 |
|
NCBI chr15:8,124,869...8,178,252
Ensembl chr15:8,125,526...8,177,781
|
|
G |
Uso1 |
USO1 vesicle transport factor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16835338 |
|
NCBI chr14:17,371,451...17,436,948
Ensembl chr14:17,371,453...17,436,897
|
|
G |
Usp13 |
ubiquitin specific peptidase 13 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16835338 |
|
NCBI chr 2:119,197,153...119,317,507
Ensembl chr 2:119,197,239...119,317,500
|
|
G |
Zfand6 |
zinc finger AN1-type containing 6 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16835338 |
|
NCBI chr 1:146,745,850...146,823,762
Ensembl chr 1:146,745,859...146,823,762
|
|
G |
Zfp267 |
zinc finger protein 267 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16835338 |
|
NCBI chr 2:122,855,036...122,873,696
Ensembl chr 2:122,865,100...122,869,616
|
|
|
G |
Cacng6 |
calcium voltage-gated channel auxiliary subunit gamma 6 |
susceptibility |
ISO |
DNA:SNP,haplotype:rs192808(human) |
RGD |
PMID:20860846 |
RGD:13524562 |
NCBI chr 1:64,307,684...64,322,124
Ensembl chr 1:64,305,438...64,321,241
|
|
G |
Ccr3 |
C-C motif chemokine receptor 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20485159, PMID:20022477 |
RGD:4145619 |
NCBI chr 8:133,026,539...133,040,999
Ensembl chr 8:133,029,625...133,040,997
|
|
G |
Cysltr1 |
cysteinyl leukotriene receptor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16502481 PMID:17641958 PMID:20485159 |
|
NCBI chr X:77,671,028...77,700,491
Ensembl chr X:77,674,150...77,700,269
|
|
G |
Cysltr2 |
cysteinyl leukotriene receptor 2 |
|
ISO |
DNA:SNPs: :-819T>G, 2078C>T, 2534A>G (human) CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16502481 PMID:20485159, PMID:15970796 |
RGD:5144000 |
NCBI chr15:54,903,290...54,941,742
Ensembl chr15:54,905,274...54,906,203
|
|
G |
Fancc |
FA complementation group C |
|
ISO |
DNA:haplotype::rs4647416(human) |
RGD |
PMID:21670957 |
RGD:11045795 |
NCBI chr17:826,512...955,703
Ensembl chr17:833,509...955,615
|
|
G |
Il4 |
interleukin 4 |
susceptibility |
ISO |
DNA:SNPs:promoter,5'UTR,intron:multiple |
RGD |
PMID:20921925 |
RGD:11528633 |
NCBI chr10:38,963,979...38,969,531
Ensembl chr10:38,963,979...38,969,531
|
|
G |
Ltc4s |
leukotriene C4 synthase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:9393345 PMID:9466979 PMID:10970818 PMID:20485159 |
|
NCBI chr10:35,736,486...35,743,088
Ensembl chr10:35,737,664...35,739,625
|
|
G |
Ms4a2 |
membrane spanning 4-domains A2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16502481 |
|
NCBI chr 1:227,957,363...227,965,312
Ensembl chr 1:227,957,302...227,965,386
|
|
G |
Postn |
periostin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18391768 |
|
NCBI chr 2:143,656,820...143,688,087
Ensembl chr 2:143,656,793...143,688,087
|
|
G |
Ptgdr2 |
prostaglandin D2 receptor 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20485159 |
|
NCBI chr 1:226,976,455...226,995,641
Ensembl chr 1:226,993,250...226,994,849
|
|
G |
Ptger2 |
prostaglandin E receptor 2 |
|
ISO |
ClinVar Annotator: match by term: Asthma, aspirin-induced, susceptibility to CTD Direct Evidence: marker/mechanism |
ClinVar CTD |
PMID:15496426 PMID:16502481 |
|
NCBI chr15:19,336,029...19,349,759
Ensembl chr15:19,338,175...19,350,210
|
|
G |
Ptgir |
prostaglandin I2 receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20485159 |
|
NCBI chr 1:78,833,449...78,835,832
Ensembl chr 1:78,833,157...78,837,623
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
ISO |
protein:increased expression:mast cell CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16502481 PMID:20485159, PMID:9487340 |
RGD:5143936 |
NCBI chr13:67,351,230...67,356,920
Ensembl chr13:67,351,087...67,359,335
|
|
G |
RT1-Ba |
RT1 class II, locus Ba |
susceptibility |
ISO |
|
RGD |
PMID:25975240 |
RGD:11074090 |
NCBI chr20:4,066,133...4,070,726
Ensembl chr20:4,066,132...4,070,721
|
|
G |
RT1-Bb |
RT1 class II, locus Bb |
susceptibility |
ISO |
|
RGD |
PMID:25975240 |
RGD:11074090 |
NCBI chr20:4,043,726...4,049,367
Ensembl chr20:4,039,413...4,049,711
|
|
G |
RT1-Db1 |
RT1 class II, locus Db1 |
susceptibility |
ISO |
|
RGD |
PMID:25975240 |
RGD:11074090 |
NCBI chr20:4,087,621...4,097,190
Ensembl chr20:4,087,618...4,097,190
|
|
G |
Tap2 |
transporter 2, ATP binding cassette subfamily B member |
|
ISO |
|
RGD |
PMID:21796142 |
RGD:5147839 |
NCBI chr20:3,995,544...4,009,587
Ensembl chr20:3,995,544...4,009,587
|
|
G |
Tbx21 |
T-box transcription factor 21 |
|
ISO |
ClinVar Annotator: match by term: Asthma, aspirin-induced, susceptibility to CTD Direct Evidence: marker/mechanism |
ClinVar CTD |
PMID:15806396 PMID:16502481 |
|
NCBI chr10:85,032,799...85,049,331
Ensembl chr10:85,032,799...85,049,331
|
|
G |
Tbxa2r |
thromboxane A2 receptor |
susceptibility |
ISO |
DNA:polymorphism: :795T>C (human) CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16502481 PMID:20485159, PMID:15898979 |
RGD:11059537 |
NCBI chr 7:11,253,153...11,259,233
Ensembl chr 7:11,253,180...11,257,977
|
|
|
G |
Alox15 |
arachidonate 15-lipoxygenase |
|
ISO |
ClinVar Annotator: match by term: Asthma, nasal polyps, and aspirin intolerance |
ClinVar |
PMID:17959182 PMID:21558275 PMID:30643255 |
|
NCBI chr10:56,953,692...56,962,145
Ensembl chr10:56,953,691...56,962,161
|
|
G |
Ptger2 |
prostaglandin E receptor 2 |
|
ISO |
|
OMIM |
|
|
NCBI chr15:19,336,029...19,349,759
Ensembl chr15:19,338,175...19,350,210
|
|
G |
Tbx21 |
T-box transcription factor 21 |
|
ISO |
ClinVar Annotator: match by term: Asthma, nasal polyps, and aspirin intolerance |
OMIM ClinVar |
PMID:25741868 |
|
NCBI chr10:85,032,799...85,049,331
Ensembl chr10:85,032,799...85,049,331
|
|
|
G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
ISO IEP |
protein:increased expression, increased nitration |
RGD |
PMID:25236742, PMID:29404485, PMID:25236742 |
RGD:14700891, RGD:14700911, RGD:14700891 |
NCBI chr 1:213,511,892...213,522,195
Ensembl chr 1:213,511,874...213,535,542
|
|
G |
Dnmt1 |
DNA methyltransferase 1 |
|
ISO |
protein:increased expression:nucleus accumbens: |
RGD |
PMID:23423140 |
RGD:9588287 |
NCBI chr 8:21,922,515...21,968,495
Ensembl chr 8:21,922,515...21,968,495
|
|
G |
Efhd2 |
EF-hand domain family, member D2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28397836 |
|
NCBI chr 5:160,407,777...160,423,811
Ensembl chr 5:160,407,778...160,423,811
|
|
G |
Mir125a |
microRNA 125a |
|
IEP |
RNA:decreased expression:neuron |
RGD |
PMID:27085842 |
RGD:26884454 |
NCBI chr 1:59,704,827...59,704,911
Ensembl chr 1:59,704,827...59,704,911
|
|
G |
Mir223 |
microRNA 223 |
|
ISO |
RNA:increased expression:serum RNA:increased expression:serum, neutrophil,liver |
RGD |
PMID:27679493, PMID:27679493 |
RGD:21408575, RGD:21408575 |
NCBI chr X:65,367,812...65,367,921
Ensembl chr X:65,367,812...65,367,921
|
|
G |
Oprl1 |
opioid related nociceptin receptor 1 |
|
ISO |
|
RGD |
PMID:29197086 |
RGD:14348965 |
NCBI chr 3:177,223,779...177,231,663
Ensembl chr 3:177,225,737...177,231,663
|
|
G |
Sirt1 |
sirtuin 1 |
|
IEP |
|
RGD |
PMID:24416161 |
RGD:9495933 |
NCBI chr20:26,831,971...26,851,587
Ensembl chr20:26,833,357...26,852,199
|
|
G |
Slc23a2 |
solute carrier family 23 member 2 |
|
IEP |
|
RGD |
PMID:27085842 |
RGD:26884454 |
NCBI chr 3:124,632,491...124,842,225
Ensembl chr 3:124,632,492...124,724,252
|
|
|
G |
Enpp2 |
ectonucleotide pyrophosphatase/phosphodiesterase 2 |
|
IEP |
protein:increased activity:plasma: |
RGD |
PMID:24361405 |
RGD:9685430 |
NCBI chr 7:94,479,931...94,563,086
Ensembl chr 7:94,480,396...94,563,001
|
|
G |
Gpx1 |
glutathione peroxidase 1 |
treatment |
IEP |
|
RGD |
PMID:24954678 |
RGD:11352769 |
NCBI chr 8:117,117,430...117,118,528
Ensembl chr 8:117,117,430...117,118,522
|
|
G |
Gpx4 |
glutathione peroxidase 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20643113 |
|
NCBI chr 7:12,516,357...12,519,154
Ensembl chr 7:12,516,352...12,519,154
|
|
G |
Gsr |
glutathione-disulfide reductase |
treatment |
IEP |
|
RGD |
PMID:24200859 |
RGD:10401881 |
NCBI chr16:62,197,617...62,239,987
Ensembl chr16:62,197,617...62,241,361
|
|
G |
Htt |
huntingtin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19845833 |
|
NCBI chr14:81,105,139...81,254,637
Ensembl chr14:81,105,139...81,254,637
|
|
G |
Il6 |
interleukin 6 |
|
IEP |
in males;protein:increased expression, increased activity:plasma (rat) |
RGD |
PMID:19462680 |
RGD:11060270 |
NCBI chr 4:3,043,231...3,047,807
Ensembl chr 4:3,043,231...3,047,807
|
|
G |
Mt3 |
metallothionein 3 |
|
ISO |
|
RGD |
PMID:20371971 |
RGD:6480494 |
NCBI chr19:11,324,708...11,326,112
Ensembl chr19:11,324,698...11,326,139
|
|
G |
Nudt1 |
nudix hydrolase 1 |
|
IEP |
|
RGD |
PMID:11817101 |
RGD:633232 |
NCBI chr12:16,391,578...16,398,771
Ensembl chr12:16,391,578...16,395,029
|
|
G |
Selenop |
selenoprotein P |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20643113 |
|
NCBI chr 2:53,105,912...53,116,198
Ensembl chr 2:53,109,684...53,114,858
|
|
|
G |
Abcb1a |
ATP binding cassette subfamily B member 1A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19625010 |
|
NCBI chr 4:22,339,829...22,517,642
Ensembl chr 4:22,133,521...22,425,515
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21041608 |
|
NCBI chr 6:137,218,398...137,239,970
Ensembl chr 6:137,218,376...137,236,258
|
|
G |
Calm1 |
calmodulin 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17205118 |
|
NCBI chr 6:124,217,241...124,225,292
Ensembl chr 6:124,217,241...124,225,292
|
|
G |
Calm2 |
calmodulin 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17205118 |
|
NCBI chr 6:11,067,675...11,080,078
Ensembl chr15:65,506,874...65,507,968
|
|
G |
Camk2b |
calcium/calmodulin-dependent protein kinase II beta |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17205118 |
|
NCBI chr14:86,208,876...86,297,727
Ensembl chr14:86,208,901...86,297,652
|
|
G |
Cnr1 |
cannabinoid receptor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19016476 |
|
NCBI chr 5:49,307,584...49,333,064
Ensembl chr 5:49,311,030...49,333,056
|
|
G |
Fdft1 |
farnesyl diphosphate farnesyl transferase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17205118 |
|
NCBI chr15:46,339,248...46,367,302
Ensembl chr15:46,339,249...46,367,302
|
|
G |
Gcc1 |
GRIP and coiled-coil domain containing 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17205118 |
|
NCBI chr 4:55,708,040...55,719,884
Ensembl chr 4:55,709,096...55,713,620
|
|
G |
LOC100911804 |
apolipoprotein L3-like |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17205118 |
|
NCBI chr 7:118,979,230...118,986,699
Ensembl chr 7:118,979,608...118,983,984
|
|
G |
Scarb1 |
scavenger receptor class B, member 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17205118 |
|
NCBI chr12:36,694,952...36,761,445
Ensembl chr12:36,694,960...36,761,455
|
|
|
G |
Hmox1 |
heme oxygenase 1 |
|
IEP IDA |
|
RGD |
PMID:20422170, PMID:19520142 |
RGD:4145288, RGD:4145306 |
NCBI chr19:14,508,634...14,515,455
Ensembl chr19:14,508,616...14,515,456
|
|
G |
Mbp |
myelin basic protein |
|
IEP |
protein:decreased expression:brain: |
RGD |
PMID:23146304 |
RGD:7327205 |
NCBI chr18:79,326,738...79,437,310
Ensembl chr18:79,326,738...79,437,310
|
|
G |
Nos1 |
nitric oxide synthase 1 |
|
IMP |
|
RGD |
PMID:14761684 |
RGD:13825130 |
NCBI chr12:44,214,949...44,405,530
Ensembl chr12:44,213,943...44,520,341
|
|
G |
Xdh |
xanthine dehydrogenase |
|
IMP IEP |
|
RGD |
PMID:17433579, PMID:8248931 |
RGD:13209022, RGD:13210748 |
NCBI chr 6:25,149,570...25,211,273
Ensembl chr 6:25,149,235...25,211,494
|
|
|
G |
Fadd |
Fas associated via death domain |
treatment |
IEP |
|
RGD |
PMID:25687490 |
RGD:11341810 |
NCBI chr 1:217,746,176...217,748,581
Ensembl chr 1:217,742,929...217,748,628
|
|
G |
Gfer |
growth factor, augmenter of liver regeneration |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:15968720 |
|
NCBI chr10:14,059,347...14,061,703
Ensembl chr10:14,059,347...14,061,703
|
|
G |
Hmox1 |
heme oxygenase 1 |
|
IEP |
|
RGD |
PMID:24748974 |
RGD:10755718 |
NCBI chr19:14,508,634...14,515,455
Ensembl chr19:14,508,616...14,515,456
|
|
G |
Ltf |
lactotransferrin |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:16141546 |
|
NCBI chr 8:119,290,416...119,313,261
Ensembl chr 8:119,290,416...119,313,261
|
|
G |
Nqo1 |
NAD(P)H quinone dehydrogenase 1 |
treatment |
IEP |
|
RGD |
PMID:23684718 |
RGD:11035220 |
NCBI chr19:38,422,210...38,437,103
Ensembl chr19:38,422,164...38,437,180
|
|
G |
Ucp2 |
uncoupling protein 2 |
|
IEP |
protein:increased expression:liver |
RGD |
PMID:19104935 |
RGD:7204431 |
NCBI chr 1:165,506,375...165,512,744
Ensembl chr 1:165,506,361...165,512,744
|
|
|
G |
Bche |
butyrylcholinesterase |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:26145887 |
|
NCBI chr 2:171,104,476...171,196,186
Ensembl chr 2:171,100,140...171,196,395
|
|
G |
Bmp2 |
bone morphogenetic protein 2 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:29800642 |
|
NCBI chr 3:126,335,963...126,346,771
Ensembl chr 3:126,335,863...126,346,318
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29959987 |
|
NCBI chr10:69,412,065...69,413,863
Ensembl chr10:69,412,017...69,413,870
|
|
G |
Csf1 |
colony stimulating factor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:32068018 |
|
NCBI chr 2:210,522,370...210,550,546
Ensembl chr 2:210,522,375...210,550,560
|
|
G |
Hbegf |
heparin-binding EGF-like growth factor |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:29305325 |
|
NCBI chr18:29,330,302...29,340,185
Ensembl chr18:29,329,764...29,340,403
|
|
G |
Il1b |
interleukin 1 beta |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:32068018 |
|
NCBI chr 3:121,876,256...121,882,637
Ensembl chr 3:121,876,263...121,882,726
|
|
G |
Mir208a |
microRNA 208a |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26454886 |
|
NCBI chr15:33,613,451...33,613,533
|
|
G |
Nos3 |
nitric oxide synthase 3 |
treatment |
ISO |
associated with Precursor Cell Lymphoblastic Leukemia-Lymphoma;DNA:polymorphism: :894G>T(human) |
RGD |
PMID:26345518 |
RGD:11533645 |
NCBI chr 4:7,321,908...7,342,404
Ensembl chr 4:7,320,668...7,342,410
|
|
G |
Nppb |
natriuretic peptide B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29959987 |
|
NCBI chr 5:164,796,176...164,797,538
Ensembl chr 5:164,796,185...164,797,531
|
|
G |
Nrg1 |
neuregulin 1 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:29305325 |
|
NCBI chr16:62,969,573...64,065,063
Ensembl chr16:63,837,216...64,057,434
|
|
G |
Rac1 |
Rac family small GTPase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28710503 |
|
NCBI chr12:13,090,316...13,111,841
Ensembl chr12:13,090,172...13,111,873
|
|
G |
Rarg |
retinoic acid receptor, gamma |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26237429 |
|
NCBI chr 7:143,840,739...143,863,206
Ensembl chr 7:143,839,980...143,863,186
|
|
G |
Tlr2 |
toll-like receptor 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29959987 |
|
NCBI chr 2:182,840,171...182,846,061
Ensembl chr 2:182,840,727...182,846,061
|
|
G |
Tnf |
tumor necrosis factor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29959987 PMID:32068018 |
|
NCBI chr20:5,189,382...5,192,000
Ensembl chr20:5,189,390...5,192,000
|
|
G |
Tp53 |
tumor protein p53 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:30009776 |
|
NCBI chr10:56,186,299...56,198,449
Ensembl chr10:56,187,020...56,198,449
|
|
|
G |
Aass |
aminoadipate-semialdehyde synthase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr 4:50,152,005...50,208,935
Ensembl chr 4:50,152,452...50,200,328
|
|
G |
Abcb11 |
ATP binding cassette subfamily B member 11 |
severity |
ISO |
DNA:SNP: :rs2287616(human) |
RGD |
PMID:27293027 |
RGD:14402413 |
NCBI chr 3:55,480,024...55,587,946
Ensembl chr 3:55,480,024...55,587,946
|
|
G |
Abcb1a |
ATP binding cassette subfamily B member 1A |
severity susceptibility |
ISO |
DNA:SNP::2677G>T/A(rs2032582)(human) CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20623750 PMID:26134275, PMID:26134275, PMID:27296832 |
RGD:11041130, RGD:14700895 |
NCBI chr 4:22,339,829...22,517,642
Ensembl chr 4:22,133,521...22,425,515
|
|
G |
Abcb1b |
ATP-binding cassette, subfamily B (MDR/TAP), member 1B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27193730 |
|
NCBI chr 4:22,225,123...22,307,577
Ensembl chr 4:22,133,521...22,425,515
|
|
G |
Abcc1 |
ATP binding cassette subfamily C member 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18466103 |
|
NCBI chr10:549,537...672,235
Ensembl chr10:549,883...672,196
|
|
G |
Abcc2 |
ATP binding cassette subfamily C member 2 |
susceptibility |
ISO |
CTD Direct Evidence: marker/mechanism DNA:polymorphism:promoter:-24C>T(human) |
CTD |
PMID:18381794 PMID:18466103, PMID:17241877, PMID:25196354 |
RGD:14700814, RGD:14700812 |
NCBI chr 1:263,554,426...263,612,556
Ensembl chr 1:263,554,453...263,613,252
|
|
G |
Abi1 |
abl-interactor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr17:89,951,662...90,033,334
Ensembl chr17:89,951,752...90,033,328
|
|
G |
Ace |
angiotensin I converting enzyme |
|
IEP |
mRNA:increased expression:liver (rat) |
RGD |
PMID:25143335 |
RGD:25671447 |
NCBI chr10:94,170,766...94,213,831
Ensembl chr10:94,170,766...94,187,822
|
|
G |
Acox3 |
acyl-CoA oxidase 3, pristanoyl |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr14:80,313,202...80,358,115
Ensembl chr14:80,314,431...80,355,420
|
|
G |
Acsl1 |
acyl-CoA synthetase long-chain family member 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr16:48,937,456...49,003,898
Ensembl chr16:48,937,456...49,003,246
|
|
G |
Actb |
actin, beta |
|
IEP ISO |
mRNA:increased expression:liver CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249, PMID:22563491 |
RGD:9587759 |
NCBI chr12:13,715,843...13,718,813
Ensembl chr12:13,715,843...13,718,841
|
|
G |
Actn4 |
actinin alpha 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr 1:87,078,012...87,147,347
Ensembl chr 1:87,078,020...87,147,333
|
|
G |
Actr3 |
actin related protein 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr13:41,695,520...41,738,622
Ensembl chr13:41,695,183...41,738,658
|
|
G |
Ada |
adenosine deaminase |
|
IEP |
protein:increased expression:liver |
RGD |
PMID:21161045 |
RGD:5128859 |
NCBI chr 3:160,115,840...160,139,947
Ensembl chr 3:160,115,842...160,139,947
|
|
G |
Adam8 |
ADAM metallopeptidase domain 8 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24646716 |
|
NCBI chr 1:212,317,510...212,332,895
Ensembl chr 1:212,317,848...212,330,349
|
|
G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:20709802 |
|
NCBI chr11:81,330,845...81,344,488
Ensembl chr11:81,330,293...81,344,488
|
|
G |
Adipor2 |
adiponectin receptor 2 |
severity |
IEP |
associated with obesity, LPS;mRNA:decreased expression:liver (rat) |
RGD |
PMID:23838384 |
RGD:8695926 |
NCBI chr 4:151,412,135...151,480,108
Ensembl chr 4:151,414,684...151,428,894
|
|
G |
Agt |
angiotensinogen |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29499335 |
|
NCBI chr19:57,321,594...57,333,460
Ensembl chr19:57,321,640...57,333,433
|
|
G |
Ahr |
aryl hydrocarbon receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21890736 |
|
NCBI chr 6:54,963,990...55,001,806
Ensembl chr 6:54,963,990...55,001,464
|
|
G |
Aifm1 |
apoptosis inducing factor, mitochondria associated 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25743375 |
|
NCBI chr X:135,304,063...135,343,062
Ensembl chr X:135,304,066...135,343,087
|
|
G |
Ak4 |
adenylate kinase 4 |
|
IEP |
protein:increased expression:liver (rat) |
RGD |
PMID:16538043 |
RGD:2301096 |
NCBI chr 5:120,250,318...120,309,153
Ensembl chr 5:120,250,616...120,305,897
|
|
G |
Akr1a1 |
aldo-keto reductase family 1 member A1 |
|
ISO |
|
RGD |
PMID:29763686 |
RGD:27226688 |
NCBI chr 5:135,482,068...135,498,693
Ensembl chr 5:135,482,068...135,498,822
|
|
G |
Alb |
albumin |
treatment |
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18779383 PMID:22310181, PMID:27567545 |
RGD:14694844 |
NCBI chr14:19,176,275...19,191,793
Ensembl chr14:19,176,277...19,191,863
|
|
G |
Aldh1l2 |
aldehyde dehydrogenase 1 family, member L2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr 7:26,375,866...26,425,838
Ensembl chr 7:26,375,866...26,425,108
|
|
G |
Aldh2 |
aldehyde dehydrogenase 2 family member |
severity susceptibility |
IEP ISO |
protein:increased expression:liver DNA:deletion:exon 3 (mouse) |
RGD |
PMID:21138988, PMID:30121625, PMID:24492981 |
RGD:7241599, RGD:15036810, RGD:14975148 |
NCBI chr12:40,466,418...40,498,813
Ensembl chr12:40,466,495...40,498,752
|
|
G |
Aldh9a1 |
aldehyde dehydrogenase 9 family, member A1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr13:85,580,828...85,597,497
Ensembl chr13:85,580,828...85,597,493
|
|
G |
Aldob |
aldolase, fructose-bisphosphate B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16115720 |
|
NCBI chr 5:64,805,772...64,818,813
Ensembl chr 5:64,805,773...64,818,824
|
|
G |
Ambp |
alpha-1-microglobulin/bikunin precursor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18779383 |
|
NCBI chr 5:78,975,690...78,986,021
Ensembl chr 5:78,975,678...78,985,990
|
|
G |
Anxa2 |
annexin A2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chr 8:75,687,134...75,723,589
Ensembl chr 8:75,687,100...75,723,594
|
|
G |
Anxa6 |
annexin A6 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr10:40,320,581...40,375,605
Ensembl chr10:40,320,581...40,375,605
|
|
G |
Apoa1 |
apolipoprotein A1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16099942 |
|
NCBI chr 8:50,525,091...50,526,875
Ensembl chr 8:50,525,091...50,526,875
|
|
G |
Apoe |
apolipoprotein E |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16099942 |
|
NCBI chr 1:80,612,894...80,616,820
Ensembl chr 1:80,612,895...80,617,057
|
|
G |
Apoh |
apolipoprotein H |
|
IEP ISO |
mRNA:increased expression:plasma: CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16099942, PMID:23288050 |
RGD:10054107 |
NCBI chr10:96,640,013...96,653,939
Ensembl chr10:96,639,924...96,653,938
|
|
G |
Arg1 |
arginase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22872058 |
|
NCBI chr 1:21,525,421...21,537,872
Ensembl chr 1:21,525,421...21,537,863
|
|
G |
Arnt |
aryl hydrocarbon receptor nuclear translocator |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20935161 |
|
NCBI chr 2:196,594,178...196,651,486
Ensembl chr 2:196,594,303...196,651,179
|
|
G |
Atg5 |
autophagy related 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22491424 |
|
NCBI chr20:49,301,783...49,393,147
Ensembl chr20:49,318,308...49,393,140
|
|
G |
Atoh8 |
atonal bHLH transcription factor 8 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chr 4:100,067,341...100,099,517
Ensembl chr 4:100,067,341...100,099,517
|
|
G |
Atp6v1d |
ATPase H+ transporting V1 subunit D |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chr 6:102,032,271...102,047,754
Ensembl chr 6:102,032,276...102,047,758
|
|
G |
Bad |
BCL2-associated agonist of cell death |
treatment |
IDA |
|
RGD |
PMID:25447754 |
RGD:10053709 |
NCBI chr 1:222,198,516...222,207,459
Ensembl chr 1:222,198,534...222,207,453
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17906064 |
|
NCBI chr 1:101,451,801...101,457,207
Ensembl chr 1:101,451,802...101,457,207
|
|
G |
Bdh1 |
3-hydroxybutyrate dehydrogenase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chr11:72,577,547...72,619,435
Ensembl chr11:72,578,533...72,614,176
|
|
G |
Bdkrb2 |
bradykinin receptor B2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:30685357 |
|
NCBI chr 6:129,399,468...129,429,676
Ensembl chr 6:129,399,468...129,429,676
|
|
G |
Blvrb |
biliverdin reductase B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr 1:84,256,063...84,273,726
Ensembl chr 1:84,256,159...84,274,075
|
|
G |
Bpnt1 |
3'(2'), 5'-bisphosphate nucleotidase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr13:103,268,045...103,292,848
Ensembl chr13:103,268,068...103,292,854
|
|
G |
Brd4 |
bromodomain containing 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr 7:14,222,101...14,303,055
Ensembl chr 7:14,222,101...14,303,055
|
|
G |
Btd |
biotinidase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15469856 |
|
NCBI chr16:7,758,192...7,791,301
Ensembl chr16:7,758,996...7,791,243
|
|
G |
C3 |
complement C3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16099942 |
|
NCBI chr 9:9,721,137...9,747,084
Ensembl chr 9:9,721,105...9,747,167
|
|
G |
Ca3 |
carbonic anhydrase 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 PMID:25231249 |
|
NCBI chr 2:88,126,519...88,136,063
Ensembl chr 2:88,126,667...88,135,410
|
|
G |
Cabp1 |
calcium binding protein 1 |
|
IEP |
protein:increased expression:liver |
RGD |
PMID:21138988 |
RGD:7241599 |
NCBI chr12:47,185,449...47,209,785
Ensembl chr12:47,179,664...47,209,784
|
|
G |
Cadps2 |
calcium dependent secretion activator 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26881866 |
|
NCBI chr 4:50,326,447...50,861,161
Ensembl chr 4:50,326,442...50,860,756
|
|
G |
Canx |
calnexin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr10:35,800,942...35,833,939
Ensembl chr10:35,800,942...35,833,861
|
|
G |
Cap1 |
cyclase associated actin cytoskeleton regulatory protein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr 5:140,559,195...140,585,494
Ensembl chr 5:140,559,206...140,585,408
|
|
G |
Casp8 |
caspase 8 |
treatment |
IEP |
|
RGD |
PMID:25447754 |
RGD:10053709 |
NCBI chr 9:65,614,142...65,662,624
Ensembl chr 9:65,614,142...65,662,106
|
|
G |
Cast |
calpastatin |
|
IEP |
|
RGD |
PMID:16871587 |
RGD:5683869 |
NCBI chr 2:1,452,111...1,561,669
Ensembl chr 2:1,452,116...1,561,464
|
|
G |
Cat |
catalase |
|
ISO IEP |
CTD Direct Evidence: marker/mechanism protein:decreased expression:liver |
CTD |
PMID:20623750 PMID:25231249, PMID:21138988 |
RGD:7241599 |
NCBI chr 3:93,379,872...93,412,058
Ensembl chr 3:93,379,874...93,412,058
|
|
G |
Ccdc80 |
coiled-coil domain containing 80 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chr11:60,645,660...60,679,249
Ensembl chr11:60,645,086...60,679,555
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
treatment |
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20623750, PMID:21813474, PMID:30663942 |
RGD:14995466, RGD:14995458 |
NCBI chr10:69,412,065...69,413,863
Ensembl chr10:69,412,017...69,413,870
|
|
G |
Ccr2 |
C-C motif chemokine receptor 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20623750 |
|
|
|
G |
Ccr5 |
C-C motif chemokine receptor 5 |
susceptibility |
ISO |
acetaminophen |
RGD |
PMID:24770590 |
RGD:14401733 |
NCBI chr 8:133,192,398...133,215,599
Ensembl chr 8:133,197,032...133,215,614
|
|
G |
Cct3 |
chaperonin containing TCP1 subunit 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr 2:187,669,051...187,693,610
Ensembl chr 2:187,668,796...187,693,610
|
|
G |
Cct5 |
chaperonin containing TCP1 subunit 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr 2:84,667,578...84,678,730
Ensembl chr 2:84,667,633...84,678,790
|
|
G |
Cdc25b |
cell division cycle 25B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chr 3:123,731,539...123,741,696
Ensembl chr 3:123,731,539...123,741,339
|
|
G |
Cds1 |
CDP-diacylglycerol synthase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chr14:9,396,511...9,456,964
Ensembl chr14:9,396,512...9,456,990
|
|
G |
Cela1 |
chymotrypsin like elastase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chr 7:142,305,337...142,318,621
Ensembl chr 7:142,305,338...142,318,620
|
|
G |
Cfap20 |
cilia and flagella associated protein 20 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr19:10,024,938...10,038,838
Ensembl chr19:10,024,947...10,038,784
|
|
G |
Cfh |
complement factor H |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr13:56,979,155...57,080,540
Ensembl chr13:56,978,607...57,080,622
|
|
G |
Chrm3 |
cholinergic receptor, muscarinic 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20197374 |
|
NCBI chr17:63,990,599...64,463,222
Ensembl chr17:63,990,599...63,994,169
|
|
G |
Ckb |
creatine kinase B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr 6:136,142,956...136,145,838
Ensembl chr 6:136,142,956...136,145,837
|
|
G |
Clu |
clusterin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20623750 |
|
NCBI chr15:42,626,612...42,665,858
Ensembl chr15:42,640,146...42,665,857
|
|
G |
Col14a1 |
collagen type XIV alpha 1 chain |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chr 7:95,054,877...95,274,073
Ensembl chr 7:95,074,236...95,273,298
|
|
G |
Col3a1 |
collagen type III alpha 1 chain |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16679477 |
|
NCBI chr 9:52,023,295...52,059,221
Ensembl chr 9:52,023,295...52,059,217
|
|
G |
Comt |
catechol-O-methyltransferase |
|
IEP |
protein:decreased expression:liver |
RGD |
PMID:21138988 |
RGD:7241599 |
NCBI chr11:86,715,981...86,735,630
Ensembl chr11:86,715,981...86,735,622
|
|
G |
Coq9 |
coenzyme Q9 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr19:10,583,855...10,596,848
Ensembl chr19:10,583,857...10,596,851
|
|
G |
Cp |
ceruloplasmin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chr 2:104,744,249...104,803,034
Ensembl chr 2:104,744,461...104,799,853
|
|
G |
Cpb2 |
carboxypeptidase B2 |
|
IEP |
mRNA,protein:increased expression,increased activity:liver,plasma |
RGD |
PMID:19386599 |
RGD:7243112 |
NCBI chr15:57,290,849...57,339,762
Ensembl chr15:57,290,849...57,339,760
|
|
G |
Cps1 |
carbamoyl-phosphate synthase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr 9:74,113,437...74,236,274
Ensembl chr 9:74,124,016...74,236,274
|
|
G |
Crp |
C-reactive protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr13:91,080,448...91,081,358
Ensembl chr13:91,054,974...91,093,713
|
|
G |
Csf3 |
colony stimulating factor 3 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:20005281 |
|
NCBI chr10:86,616,785...86,619,160
Ensembl chr10:86,616,785...86,619,157
|
|
G |
Ctnnb1 |
catenin beta 1 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:19679878 |
|
NCBI chr 8:129,601,511...129,628,378
Ensembl chr 8:129,617,812...129,627,372
|
|
G |
Ctse |
cathepsin E |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chr13:48,426,833...48,449,493
Ensembl chr13:48,426,820...48,449,490
|
|
G |
Cxcl1 |
C-X-C motif chemokine ligand 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16118408 |
|
NCBI chr14:18,743,678...18,745,457
Ensembl chr14:18,743,685...18,745,457
|
|
G |
Cxcl10 |
C-X-C motif chemokine ligand 10 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:11739529 |
|
NCBI chr14:17,210,733...17,212,930
Ensembl chr14:17,210,733...17,212,930
|
|
G |
Cxcl3 |
C-X-C motif chemokine ligand 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16118408 |
|
NCBI chr14:18,820,168...18,839,659
Ensembl chr14:18,820,168...18,839,595
|
|
G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28762043 |
|
NCBI chr 8:62,451,360...62,458,244
Ensembl chr 8:62,451,329...62,458,301
|
|
G |
Cyp27b1 |
cytochrome P450, family 27, subfamily b, polypeptide 1 |
|
ISO |
mRNA, protein:decreased expression:kidney (mouse) |
RGD |
PMID:26476181 |
RGD:25671412 |
NCBI chr 7:70,333,150...70,340,006
Ensembl chr 7:70,335,061...70,340,005
|
|
G |
Cyp2a3 |
cytochrome P450, family 2, subfamily a, polypeptide 3 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:23628428 |
|
NCBI chr 1:83,653,248...83,662,118
Ensembl chr 1:83,653,234...83,766,484
|
|
G |
Cyp2b3 |
cytochrome P450, family 2, subfamily b, polypeptide 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28762043 |
|
NCBI chr 1:83,163,103...83,236,615
Ensembl chr 1:83,163,079...83,236,615
|
|
G |
Cyp2c11 |
cytochrome P450, subfamily 2, polypeptide 11 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chr 1:257,676,172...258,004,428
Ensembl chr 1:257,970,345...258,004,434
|
|
G |
Cyp2c6v1 |
cytochrome P450, family 2, subfamily C, polypeptide 6, variant 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12963435 PMID:28762043 |
|
NCBI chr 1:147,713,879...147,814,410
Ensembl chr 1:147,713,892...147,888,007
|
|
G |
Cyp2d4 |
cytochrome P450, family 2, subfamily d, polypeptide 4 |
|
ISO |
DNA:hypermethylation:promoter |
RGD |
PMID:27490558 |
RGD:14700879 |
NCBI chr 7:123,599,264...123,608,436
Ensembl chr 7:123,599,266...123,608,436
|
|
G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
treatment |
ISO IEP |
CTD Direct Evidence: marker/mechanism DNA:hypermethylation:promoter associated with Endotoxemia |
CTD |
PMID:12668988 PMID:16770646 PMID:21741958 PMID:28762043, PMID:27960551, PMID:27490558, PMID:27324775, PMID:29404441, PMID:25681370 |
RGD:14700901, RGD:14700879, RGD:14700878, RGD:14700873, RGD:14700872 |
NCBI chr 1:213,511,892...213,522,195
Ensembl chr 1:213,511,874...213,535,542
|
|
G |
Cyp3a23-3a1 |
cytochrome P450, family 3, subfamily a, polypeptide 23-polypeptide 1 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20623750 |
|
NCBI chr12:11,053,888...11,082,742
Ensembl chr12:11,655,402...11,733,136
|
|
G |
Cyp3a62 |
cytochrome P450, family 3, subfamily a, polypeptide 62 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28762043 |
|
NCBI chr12:18,679,809...18,709,397
Ensembl chr12:18,678,594...18,709,397
|
|
G |
Cyp4a3 |
cytochrome P450, family 4, subfamily a, polypeptide 3 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr 5:134,468,666...134,484,851
Ensembl chr 5:134,469,270...134,484,839
|
|
G |
Cyp8b1 |
cytochrome P450 family 8 subfamily B member 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25448281 |
|
NCBI chr 8:130,548,418...130,550,388
Ensembl chr 8:130,548,418...130,550,388
|
|
G |
Dbt |
dihydrolipoamide branched chain transacylase E2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr 2:219,563,783...219,592,651
Ensembl chr 2:219,563,783...219,592,650
|
|
G |
Ddb1 |
damage-specific DNA binding protein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr 1:226,657,561...226,683,356
Ensembl chr 1:226,657,561...226,683,347
|
|
G |
Dgat2 |
diacylglycerol O-acyltransferase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17984051 |
|
NCBI chr 1:164,113,459...164,143,818
Ensembl chr 1:164,113,459...164,143,818
|
|
G |
Dhfr |
dihydrofolate reductase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19648163 |
|
NCBI chr 2:21,931,887...21,958,927
Ensembl chr 2:21,931,493...21,962,453
|
|
G |
Dhrs7 |
dehydrogenase/reductase 7 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chr 6:95,522,577...95,541,393
Ensembl chr 6:95,522,577...95,541,393
|
|
G |
Dlat |
dihydrolipoamide S-acetyltransferase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr 8:55,062,549...55,087,832
Ensembl chr 8:55,062,551...55,087,832
|
|
G |
Dnajb9 |
DnaJ heat shock protein family (Hsp40) member B9 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26881866 |
|
NCBI chr 6:64,165,913...64,170,122
Ensembl chr 6:64,165,913...64,170,151
|
|
G |
Dnajc12 |
DnaJ heat shock protein family (Hsp40) member C12 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26881866 |
|
NCBI chr20:26,893,139...26,913,041
Ensembl chr20:26,893,016...26,913,016
|
|
G |
Dsc2 |
desmocollin 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chr18:11,826,705...11,858,801
Ensembl chr18:11,826,706...11,858,754
|
|
G |
E2f1 |
E2F transcription factor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:30515189 |
|
NCBI chr 3:150,062,895...150,073,721
Ensembl chr 3:150,047,826...150,073,721
|
|
G |
Echdc1 |
ethylmalonyl-CoA decarboxylase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chr 1:30,874,410...30,921,117
Ensembl chr 1:30,874,418...30,917,882
|
|
G |
Echs1 |
enoyl-CoA hydratase, short chain 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr 1:212,570,213...212,579,040
Ensembl chr 1:212,570,195...212,579,057
|
|
G |
Edem1 |
ER degradation enhancing alpha-mannosidase like protein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chr 4:140,886,644...140,918,654
Ensembl chr 4:140,886,545...140,915,779
|
|
G |
Eif2ak1 |
eukaryotic translation initiation factor 2 alpha kinase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25411909 |
|
NCBI chr12:12,749,026...12,782,078
Ensembl chr12:12,748,785...12,782,146
|
|
G |
Eif4ebp2 |
eukaryotic translation initiation factor 4E binding protein 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr20:31,055,292...31,072,469
Ensembl chr20:31,055,789...31,072,469
|
|
G |
Endog |
endonuclease G |
|
IEP |
protein:decreased expression:mitochondrion: |
RGD |
PMID:22509279 |
RGD:9685364 |
NCBI chr 3:8,741,833...8,744,414
Ensembl chr 3:8,741,766...8,744,592
|
|
G |
Eng |
endoglin |
|
IEP |
protein:increased expression:liver (rat) |
RGD |
PMID:21146604 |
RGD:7257529 |
NCBI chr 3:11,679,530...11,717,486
Ensembl chr 3:11,679,530...11,717,485
|
|
G |
Eno1 |
enolase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16099942 PMID:25231249 |
|
NCBI chr 5:167,288,223...167,299,610
Ensembl chr 5:167,288,223...167,299,609
|
|
G |
Enpp2 |
ectonucleotide pyrophosphatase/phosphodiesterase 2 |
|
IEP |
protein:increased activity:serum: |
RGD |
PMID:17850827 |
RGD:9685426 |
NCBI chr 7:94,479,931...94,563,086
Ensembl chr 7:94,480,396...94,563,001
|
|
G |
Ephx1 |
epoxide hydrolase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chr13:99,271,390...99,300,580
Ensembl chr13:99,271,366...99,300,579
|
|
G |
Erlec1 |
endoplasmic reticulum lectin 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26881866 |
|
NCBI chr14:115,314,890...115,352,871
Ensembl chr14:115,314,890...115,352,562
|
|
G |
Ern1 |
endoplasmic reticulum to nucleus signaling 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:30538632 |
|
NCBI chr10:94,588,555...94,682,072
Ensembl chr10:94,588,555...94,681,914
|
|
G |
F13a1 |
coagulation factor XIII A1 chain |
|
ISO |
|
RGD |
PMID:22019897 |
RGD:11041813 |
NCBI chr17:28,504,650...28,680,015
Ensembl chr17:28,504,623...28,680,362
|
|
G |
F2rl3 |
F2R like thrombin or trypsin receptor 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20974703 |
|
NCBI chr16:18,817,797...18,819,790
Ensembl chr16:18,814,622...18,819,833
|
|
G |
F3 |
coagulation factor III, tissue factor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22407844 |
|
NCBI chr 2:225,310,686...225,322,281
Ensembl chr 2:225,310,624...225,322,272
|
|
G |
Fadd |
Fas associated via death domain |
treatment |
IEP |
|
RGD |
PMID:26062544, PMID:25447754 |
RGD:11341803, RGD:10053709 |
NCBI chr 1:217,746,176...217,748,581
Ensembl chr 1:217,742,929...217,748,628
|
|
G |
Fads1 |
fatty acid desaturase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chr 1:226,234,034...226,249,118
Ensembl chr 1:226,234,074...226,249,138
|
|
G |
Fads2 |
fatty acid desaturase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chr 1:225,906,582...226,152,568
Ensembl chr 1:226,114,413...226,152,524
|
|
G |
Fas |
Fas cell surface death receptor |
|
IEP |
protein:increased expression:liver (rat) |
RGD |
PMID:16831245 |
RGD:8662853 |
NCBI chr 1:252,589,785...252,624,790
Ensembl chr 1:252,589,785...252,624,790
|
|
G |
Fasn |
fatty acid synthase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chr10:109,987,735...110,005,901
Ensembl chr10:109,987,735...110,005,901
|
|
G |
Fcmr |
Fc fragment of IgM receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chr13:47,602,701...47,617,065
Ensembl chr13:47,602,692...47,617,064
|
|
G |
Fga |
fibrinogen alpha chain |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20974703 |
|
NCBI chr 2:181,997,562...182,013,726
Ensembl chr 2:182,006,242...182,013,763
|
|
G |
Fgf21 |
fibroblast growth factor 21 |
severity |
IEP |
mRNA:increased expression:liver (rat) |
RGD |
PMID:29883717 |
RGD:15045603 |
NCBI chr 1:101,595,579...101,596,822
Ensembl chr 1:101,595,579...101,596,822
|
|
G |
Flt1 |
Fms related receptor tyrosine kinase 1 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:21135413 |
|
NCBI chr12:9,033,993...9,205,886
Ensembl chr12:9,034,308...9,205,905
|
|
G |
Fmo3 |
flavin containing dimethylaniline monoxygenase 3 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:24973094 |
|
NCBI chr13:80,837,418...80,856,214
Ensembl chr13:80,837,420...80,862,963
|
|
G |
Ftl1 |
ferritin light chain 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr 1:101,448,190...101,450,034
Ensembl chr 1:101,448,346...101,449,829
|
|
G |
G6pc1 |
glucose-6-phosphatase catalytic subunit 1 |
|
ISO |
mRNA:decreased expression:liver (mouse) |
RGD |
PMID:28189721 |
RGD:14695531 |
NCBI chr10:89,286,009...89,296,213
Ensembl chr10:89,285,855...89,296,213
|
|
G |
G6pd |
glucose-6-phosphate dehydrogenase |
treatment |
IEP |
|
RGD |
PMID:21864513 |
RGD:10449168 |
NCBI chr X:156,274,800...156,293,935
Ensembl chr X:156,274,800...156,293,926
|
|
G |
Gadd45a |
growth arrest and DNA-damage-inducible, alpha |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20623750 |
|
NCBI chr 4:97,782,512...97,784,814
Ensembl chr 4:97,782,512...97,784,842
|
|
G |
Ganab |
glucosidase II alpha subunit |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr 1:225,096,558...225,116,384
Ensembl chr 1:225,096,598...225,116,378
|
|
G |
Gc |
GC, vitamin D binding protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16099942 |
|
NCBI chr14:20,267,023...20,302,577
Ensembl chr14:20,266,891...20,302,581
|
|
G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
|
IMP ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19481141, PMID:17573345 |
RGD:10402383 |
NCBI chr 8:85,059,051...85,097,471
Ensembl chr 8:85,059,051...85,097,468
|
|
G |
Gclm |
glutamate cysteine ligase, modifier subunit |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr 2:225,827,504...225,847,876
Ensembl chr 2:225,827,504...225,847,874
|
|
G |
Gda |
guanine deaminase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr 1:238,982,542...239,057,663
Ensembl chr 1:238,982,392...239,057,732
|
|
G |
Gdi1 |
GDP dissociation inhibitor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr X:156,400,734...156,407,396
Ensembl chr X:156,400,736...156,407,404
|
|
G |
Gfer |
growth factor, augmenter of liver regeneration |
treatment |
ISO IDA |
|
RGD |
PMID:22033404, PMID:15968720 |
RGD:9685722, RGD:9685727 |
NCBI chr10:14,059,347...14,061,703
Ensembl chr10:14,059,347...14,061,703
|
|
G |
Ggh |
gamma-glutamyl hydrolase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21219404 |
|
NCBI chr 5:34,040,258...34,063,369
Ensembl chr 5:34,040,258...34,063,361
|
|
G |
Ggt1 |
gamma-glutamyltransferase 1 |
|
IEP |
|
RGD |
PMID:10934156 |
RGD:14701049 |
NCBI chr20:14,019,723...14,045,781
Ensembl chr20:14,019,723...14,025,068
|
|
G |
Got1 |
glutamic-oxaloacetic transaminase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chr 1:263,246,248...263,269,762
Ensembl chr 1:263,246,248...263,269,762
|
|
G |
Gpd1 |
glycerol-3-phosphate dehydrogenase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr 7:141,368,928...141,377,931
Ensembl chr 7:141,370,491...141,377,928
|
|
G |
Gpt |
glutamic--pyruvic transaminase |
treatment |
ISO IEP |
CTD Direct Evidence: marker/mechanism protein:increased expression, activity:serum: |
CTD |
PMID:145039 PMID:19481104, PMID:19085960, PMID:19085960, PMID:27293452, PMID:21772750, PMID:28487901 |
RGD:14975249, RGD:14975249, RGD:14975168, RGD:14975166, RGD:14975162 |
NCBI chr 7:117,759,083...117,761,932
Ensembl chr 7:117,759,083...117,761,931
|
|
G |
Gpt2 |
glutamic--pyruvic transaminase 2 |
|
IEP ISO |
protein:increased expression, activity:serum: |
RGD |
PMID:19085960, PMID:19085960 |
RGD:14975249, RGD:14975249 |
NCBI chr19:22,599,003...22,633,529
Ensembl chr19:22,590,881...22,632,071
|
|
G |
Grk4 |
G protein-coupled receptor kinase 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr14:81,261,708...81,339,516
Ensembl chr14:81,265,672...81,339,526
|
|
G |
Gsn |
gelsolin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16099942 |
|
NCBI chr 3:14,456,106...14,508,922
Ensembl chr 3:14,467,330...14,508,911
|
|
G |
Gsr |
glutathione-disulfide reductase |
treatment |
IEP ISO |
mRNA, protein:increased expression:liver CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 PMID:28069987, PMID:23554813, PMID:24154663 |
RGD:7257532, RGD:10401878 |
NCBI chr16:62,197,617...62,239,987
Ensembl chr16:62,197,617...62,241,361
|
|
G |
Gsta4 |
glutathione S-transferase alpha 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr 8:85,497,557...85,514,732
Ensembl chr 8:85,497,557...85,518,879
|
|
G |
Gstm1 |
glutathione S-transferase mu 1 |
no_association |
ISO IEP |
CTD Direct Evidence: marker/mechanism protein:increased expression:liver |
CTD |
PMID:17465707 PMID:18666253, PMID:25501156, PMID:24465778, PMID:24903797, PMID:29523098, PMID:21138988 |
RGD:14700970, RGD:14700959, RGD:14700941, RGD:14700937, RGD:7241599 |
NCBI chr 2:210,803,869...210,809,461
Ensembl chr 2:210,803,869...210,809,306
|
|
G |
Gstm2 |
glutathione S-transferase mu 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20623750 |
|
NCBI chr 2:210,778,041...210,782,807
Ensembl chr 2:210,720,704...210,782,856
|
|
G |
Gstm3 |
glutathione S-transferase mu 3 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:25743375 |
|
NCBI chr 2:210,685,204...210,688,273
Ensembl chr 2:210,685,197...210,688,272
|
|
G |
Gstm4 |
glutathione S-transferase mu 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chr 2:210,834,013...210,839,242
Ensembl chr 2:210,833,884...210,839,295
|
|
G |
Gstm5 |
glutathione S-transferase, mu 5 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:25743375 |
|
NCBI chr 2:210,685,338...210,688,133
Ensembl chr 2:210,685,197...210,688,272
|
|
G |
Gsto1 |
glutathione S-transferase omega 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr 1:267,607,437...267,617,387
Ensembl chr 1:267,607,418...267,617,387
|
|
G |
Gstp1 |
glutathione S-transferase pi 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20623750 PMID:25226513 |
|
NCBI chr 1:219,291,679...219,294,147
Ensembl chr 1:219,291,679...219,294,147
|
|
G |
Gstt1 |
glutathione S-transferase theta 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18397238 PMID:18666253 PMID:25226513 |
|
NCBI chr20:13,799,102...13,816,527
Ensembl chr20:13,799,102...13,816,526
|
|
G |
H2ax |
H2A.X variant histone |
treatment |
IDA |
|
RGD |
PMID:23265463 |
RGD:8693741 |
NCBI chr 8:48,665,652...48,666,981
Ensembl chr 8:48,665,652...48,666,981
|
|
G |
Hacl1 |
2-hydroxyacyl-CoA lyase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26881866 |
|
NCBI chr16:7,720,047...7,758,119
Ensembl chr16:7,714,465...7,758,189
|
|
G |
Hadha |
hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chr 6:27,589,840...27,628,921
Ensembl chr 6:27,589,657...27,629,175
|
|
G |
Hamp |
hepcidin antimicrobial peptide |
|
IEP |
mRNA:increased expression:hepatocyte |
RGD |
PMID:24373749 |
RGD:11041724 |
NCBI chr 1:89,368,021...89,369,960
Ensembl chr 1:89,368,021...89,369,960
|
|
G |
Hao2 |
hydroxyacid oxidase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chr 2:200,785,492...200,808,868
Ensembl chr 2:200,778,122...200,808,857
|
|
G |
Havcr1 |
hepatitis A virus cellular receptor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20623750 |
|
NCBI chr10:31,813,819...31,860,934
Ensembl chr10:31,813,814...31,848,379
|
|
G |
Hba-a1 |
hemoglobin alpha, adult chain 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chr10:15,602,794...15,603,649
Ensembl chr10:15,602,794...15,603,649
|
|
G |
Hmgb1 |
high mobility group box 1 |
treatment |
ISO IEP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19783637, PMID:29091898 |
RGD:15090820 |
NCBI chr12:7,082,529...7,090,246
Ensembl chr16:37,500,017...37,502,237
|
|
G |
Hmox1 |
heme oxygenase 1 |
treatment |
IEP ISO |
CTD Direct Evidence: marker/mechanism|therapeutic |
CTD |
PMID:18227147 PMID:22688006, PMID:22886620, PMID:29091898 |
RGD:10762620, RGD:15090820 |
NCBI chr19:14,508,634...14,515,455
Ensembl chr19:14,508,616...14,515,456
|
|
G |
Hpd |
4-hydroxyphenylpyruvate dioxygenase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16099942 PMID:22872058 |
|
NCBI chr12:38,828,606...38,839,956
Ensembl chr12:38,828,444...38,839,969
|
|
G |
Hprt1 |
hypoxanthine phosphoribosyltransferase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr X:158,196,640...158,228,815
Ensembl chr X:158,197,149...158,228,749
|
|
G |
Hpx |
hemopexin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16099942 |
|
NCBI chr 1:170,423,558...170,431,066
Ensembl chr 1:170,423,483...170,431,073
|
|
G |
Hrh2 |
histamine receptor H 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22926047 |
|
NCBI chr17:10,912,959...10,931,389
Ensembl chr17:10,921,507...10,952,441
|
|
G |
Hspa5 |
heat shock protein family A (Hsp70) member 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr 3:13,838,304...13,842,763
Ensembl chr 3:13,838,304...13,842,762
|
|
G |
Hspa8 |
heat shock protein family A (Hsp70) member 8 |
|
IEP |
protein:altered localization:liver (rat) |
RGD |
PMID:12376827 |
RGD:10059389 |
NCBI chr 8:44,989,401...44,993,261
Ensembl chr 8:44,990,014...44,993,179
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
treatment |
IEP |
|
RGD |
PMID:29091898 |
RGD:15090820 |
NCBI chr 8:22,035,287...22,047,049
Ensembl chr 8:22,035,256...22,047,059
|
|
G |
Idh2 |
isocitrate dehydrogenase (NADP(+)) 2 |
severity |
ISO |
|
RGD |
PMID:31121248 |
RGD:14985250 |
NCBI chr 1:141,874,354...141,893,674
Ensembl chr 1:141,866,283...141,893,705
|
|
G |
Ido2 |
indoleamine 2,3-dioxygenase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:32289347 |
|
NCBI chr16:72,232,852...72,291,227
Ensembl chr16:72,268,943...72,289,156
|
|
G |
Ifng |
interferon gamma |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12153990 PMID:21245496, PMID:30013034 |
RGD:14975100 |
NCBI chr 7:61,337,383...61,341,419
Ensembl chr 7:61,337,381...61,341,419
|
|
G |
Igf1 |
insulin-like growth factor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23639586 PMID:25226513 |
|
NCBI chr 7:28,412,123...28,491,815
Ensembl chr 7:28,412,198...28,486,609
|
|
G |
Il11 |
interleukin 11 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:11421492 |
|
NCBI chr 1:72,636,959...72,643,255
Ensembl chr 1:72,635,267...72,643,255
|
|
G |
Il17a |
interleukin 17A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19633216 PMID:24949944 |
|
NCBI chr 9:26,841,299...26,844,786
Ensembl chr 9:26,841,299...26,844,786
|
|
G |
Il18 |
interleukin 18 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19164858 |
|
NCBI chr 8:55,009,666...55,016,286
Ensembl chr 8:54,993,859...55,016,299
|
|
G |
Il1a |
interleukin 1 alpha |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:8218930 |
|
NCBI chr 3:121,824,712...121,836,122
Ensembl chr 3:121,825,412...121,836,086
|
|
G |
Il1b |
interleukin 1 beta |
treatment |
IDA IEP ISO |
CTD Direct Evidence: marker/mechanism|therapeutic |
CTD |
PMID:19164858 PMID:28138970, PMID:23102243, PMID:29091898, PMID:31342809, PMID:31077717, PMID:29278859 |
RGD:7204421, RGD:15090820, RGD:15036799, RGD:14975281, RGD:13793380 |
NCBI chr 3:121,876,256...121,882,637
Ensembl chr 3:121,876,263...121,882,726
|
|
G |
Il1r2 |
interleukin 1 receptor type 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17984051 |
|
NCBI chr 9:46,840,646...46,881,241
Ensembl chr 9:46,840,992...46,881,264
|
|
G |
Il22 |
interleukin 22 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:15122762 PMID:16212920 PMID:23375450 |
|
NCBI chr 7:61,236,037...61,240,502
Ensembl chr 7:61,236,037...61,240,502
|
|
G |
Il4 |
interleukin 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism|therapeutic |
CTD |
PMID:21094227 PMID:21735453 PMID:22107450 |
|
NCBI chr10:38,963,979...38,969,531
Ensembl chr10:38,963,979...38,969,531
|
|
G |
Il6 |
interleukin 6 |
treatment |
ISO IEP |
CTD Direct Evidence: therapeutic |
CTD |
PMID:7532385 PMID:15763341, PMID:29091898 |
RGD:15090820 |
NCBI chr 4:3,043,231...3,047,807
Ensembl chr 4:3,043,231...3,047,807
|
|
G |
Immt |
inner membrane mitochondrial protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr 4:99,753,446...99,789,921
Ensembl chr 4:99,753,500...99,792,484
|
|
G |
Irak1 |
interleukin-1 receptor-associated kinase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr X:156,716,469...156,726,367
Ensembl chr X:156,716,604...156,725,977
|
|
G |
Itpr1 |
inositol 1,4,5-trisphosphate receptor, type 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chr 4:140,247,297...140,580,749
Ensembl chr 4:140,247,313...140,580,748
|
|
G |
Jund |
JunD proto-oncogene, AP-1 transcription factor subunit |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:30515189 |
|
NCBI chr16:20,485,028...20,486,707
Ensembl chr16:20,485,029...20,486,707
|
|
G |
Keap1 |
Kelch-like ECH-associated protein 1 |
|
ISO |
|
RGD |
PMID:18417483 |
RGD:6893370 |
NCBI chr 8:22,250,518...22,259,868
Ensembl chr 8:22,250,518...22,259,779
|
|
G |
Kitlg |
KIT ligand |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:12594235 |
|
NCBI chr 7:42,269,784...42,351,054
Ensembl chr 7:42,269,784...42,351,054
|
|
G |
Kng2 |
kininogen 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20362651 PMID:30685357 |
|
NCBI chr11:81,509,185...81,516,759
|
|
G |
Krt18 |
keratin 18 |
|
ISO |
CTD Direct Evidence: marker/mechanism mRNA, protein:increased expression:liver (mouse) |
CTD |
PMID:19783637, PMID:17340120 |
RGD:18337498 |
NCBI chr 7:143,629,455...143,633,131
Ensembl chr 7:143,629,455...143,633,131
|
|
G |
Krt8 |
keratin 8 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr 7:143,596,511...143,603,745
Ensembl chr 7:143,596,511...143,603,803
|
|
G |
Lap3 |
leucine aminopeptidase 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr14:70,102,813...70,121,797
Ensembl chr14:70,102,814...70,121,797
|
|
G |
Lbp |
lipopolysaccharide binding protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chr 3:154,786,232...154,812,910
Ensembl chr 3:154,786,215...154,813,464
|
|
G |
Lcn2 |
lipocalin 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20362651 PMID:20623750 |
|
NCBI chr 3:11,414,189...11,417,534
Ensembl chr 3:11,414,186...11,417,546
|
|
G |
Lgals3 |
galectin 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22461450 |
|
NCBI chr15:24,153,602...24,165,537
Ensembl chr15:24,141,651...24,165,537
|
|
G |
LOC100364500 |
RT1 class I, locus CE11-like |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21570397 PMID:28043905 |
|
NCBI chr20:2,704,153...2,707,111
Ensembl chr20:2,704,148...2,707,120
|
|
G |
Lpl |
lipoprotein lipase |
treatment |
IEP |
|
RGD |
PMID:27071702 |
RGD:13794380 |
NCBI chr16:22,537,687...22,561,487
Ensembl chr16:22,537,056...22,561,496
|
|
G |
Lrat |
lecithin retinol acyltransferase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chr 2:181,896,304...181,905,366
Ensembl chr 2:181,896,305...181,905,300
|
|
G |
Ltb4r |
leukotriene B4 receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28487374 |
|
NCBI chr15:34,449,299...34,453,352
Ensembl chr15:34,452,116...34,453,171
|
|
G |
Ltf |
lactotransferrin |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:16141546 |
|
NCBI chr 8:119,290,416...119,313,261
Ensembl chr 8:119,290,416...119,313,261
|
|
G |
Map1lc3b |
microtubule-associated protein 1 light chain 3 beta |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chr19:53,635,449...53,643,970
Ensembl chr19:53,629,779...53,646,058
|
|
G |
Map3k5 |
mitogen-activated protein kinase kinase kinase 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18700144 |
|
NCBI chr 1:15,412,603...15,613,752
Ensembl chr 1:15,412,603...15,613,746
|
|
G |
Mat1a |
methionine adenosyltransferase 1A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr16:18,690,649...18,709,135
Ensembl chr16:18,690,246...18,709,133
|
|
G |
Mccc1 |
methylcrotonoyl-CoA carboxylase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr 2:122,550,777...122,690,540
Ensembl chr 2:122,550,775...122,690,617
|
|
G |
Mdh1 |
malate dehydrogenase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16099942 |
|
NCBI chr14:106,378,349...106,393,642
Ensembl chr14:106,378,942...106,393,670
|
|
G |
Me1 |
malic enzyme 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr 8:94,256,830...94,368,834
Ensembl chr 8:94,256,839...94,368,834
|
|
G |
Med1 |
mediator complex subunit 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16109766 |
|
NCBI chr10:86,101,560...86,145,271
Ensembl chr10:86,103,600...86,144,880
|
|
G |
Mir100 |
microRNA 100 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28545106 |
|
NCBI chr 8:45,746,948...45,747,027
Ensembl chr 8:45,746,948...45,747,027
|
|
G |
Mir103a1 |
microRNA 103a-1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22363424 |
|
NCBI chr10:20,606,715...20,606,800
Ensembl chr10:20,606,715...20,606,800
|
|
G |
Mir106b |
microRNA 106b |
|
IEP IDA |
miRNA:decreased expression:liver (rat) DNA:hypermethylation:promoter |
RGD |
PMID:29554950, PMID:29554950 |
RGD:15042854, RGD:15042854 |
NCBI chr12:19,307,752...19,307,833
Ensembl chr12:19,307,752...19,307,833
|
|
G |
Mir107 |
microRNA 107 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25359176 PMID:28545106 |
|
NCBI chr 1:253,128,250...253,128,336
Ensembl chr 1:253,128,250...253,128,336
|
|
G |
Mir10a |
microRNA 10a |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22363424 |
|
NCBI chr10:84,165,950...84,166,059
Ensembl chr10:84,165,950...84,166,059
|
|
G |
Mir10b |
microRNA 10b |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22363424 |
|
NCBI chr 3:61,647,978...61,648,086
Ensembl chr 3:61,647,978...61,648,086
|
|
G |
Mir122 |
microRNA 122 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22045675 PMID:22363424 PMID:25359176 PMID:25527335 PMID:26489516 PMID:28545106 PMID:28844483 |
|
NCBI chr18:60,755,285...60,755,369
|
|
G |
Mir1249 |
microRNA 1249 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28545106 |
|
NCBI chr 7:125,861,192...125,861,311
Ensembl chr 7:125,861,192...125,861,311
|
|
G |
Mir125b1 |
microRNA 125b-1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28545106 |
|
NCBI chr 8:45,798,260...45,798,346
Ensembl chr 8:45,798,260...45,798,346
|
|
G |
Mir125b2 |
microRNA 125b-2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28545106 |
|
NCBI chr11:16,097,346...16,097,433
|
|
G |
Mir1306 |
microRNA 1306 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28545106 |
|
NCBI chr11:86,857,633...86,857,705
Ensembl chr11:86,857,632...86,857,711
|
|
G |
Mir130a |
microRNA 130a |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25359176 PMID:28545106 |
|
NCBI chr 3:72,141,037...72,141,124
Ensembl chr 3:72,141,037...72,141,124
|
| |